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Abstract 
Background   
Diabetes Mellitus (DM)incidence is growing rapidly globally and represents 
major challenges to public health, economy and social developments.DM is  
considered as one of the most important risk factors of  cardiovascular disease 
(CVD).Moreover it is associated with the presence of other risk factors of CVD 
including  obesity ,dyslipidemia and  hypertension which increase the risk of 
having  CVD and causing premature death and disability among diabetic 
patients . 
The aim of the study: 
To determine the prevalence of cardiovascular risk factors, including 
hypertension,  
obesity, physical inactivity, dyslipidemia and  smoking among patients with 
Type 2 DM at the diabetic clinics in the Bethlehem Health Directorate . 
 
Method: 
This is across sectional study through stratified random sample that was carried 
out in 5 diabetic clinics of Ministry of Health (MoH). The total number of 
participants was233in the period between June to November 2016 . 
Results: 
Results showed that 100 of 233 participants were having CVD which 
represented 43% of our sample ,the rest were not having CVD but having high 
prevalence rate of risk factors of CVD. 
Prevalence rate of risk factors of CVD among 133 patients : 
There were a statistical significant difference in both total cholesterol and 
obesity within the gender (p=.0001) in which females had a higher prevalence 
 IV 
 
than males by 80.2% and 83% respectively. Furthermore, results showed that 
approximately more than one-fifth  of participants were overweight  by 23.3% . 
Physical inactivity was the highest prevalence among other risk factors by 
86.5% and sedentary lifestyle mean was 12.1±3.3 hours with statistical 
significant difference with age (P=0.001), gender (p=.022)and duration of 
diabetes (p=.005) . 
Hypertension was observed in 66.2% of participants with no statistical 
difference and smoking was the lowest prevalence rate by 6.8% for current 
smokers .  
Also results showed that age was significantly associated with the risk of 
coronary heart disease CHD (p=.0001), while, age and duration of diabetes 
were statistically associated with stroke p=.0001 and p=.001 respectively . 
With lipid analysis , results showed that total cholesterol was statically 
associated with gender (p=.004) and the same for triglycerides (P=.002 ). 
Conclusion: 
The number of diabetics is increasing every year in Palestine, with many 
factors pushing for this increase, such as changing the lifestyle and 
urbanization as well as obesity. Screening and early detection for diabetes are 
necessary to reduce  the incidence of diabetes and reduce cardiovascular 
morbidity and mortality. Moreover , monitoring and controlling  risk factors of 
CVD by providing effective treatment could decrease or delay the onset of 
CVD . 
 
 
 
 
Vبٍُ يرظً انسكرٌ انُىع  انذيىَت  ىالأوعُتيعذل اَخشبر  بعط عىايم انخطىرة لأيراض انقهب
 ) فٍ يذَرَت  صحت بُج نحى .dnuopmocانثبٍَ انًعبنجٍُ ببلأَسىنٍُ والأَسىنٍُ والأقراص   (
إعذاد : غبدة يحًىد إبراهُى  شعفىط 
: د. أسًً إيبو  إشراف
:ِٔرض اُ
٣عزاز ٓؼسٍ الإطبثخ ثٔطع اُؽٌط١ ػبُٔ٤ب ٝٛصا ٣شٌَ رحس٣بد ضئ٤ؽ٤خ ُِظحخ اُؼبٓخ ٝاُز٘ٔ٤خ 
اُوِت  لأٓطاعػٞآَ اُرطٞضح  أْٛالاهزظبز٣خ ٝالاعزٔبػ٤خ . ٣ؼزجط ٓطع اُؽٌط١ ٝاحسا ٖٓ 
 ٝالأٝػ٤خاُوِت  لأٓطاع ذطٞضح أذطٟ ػٞآَ ٞعٞزث ٣طرجؾٚ شُي،كئٗ ػِ٠ اُسٓٞ٣خ ػلاٝح ٝالأٝػ٤خ
ثأٓطاع  الإطبثخ ذطط ٖٓ رع٣س اُسّ ٝاُز٢ ػـؾ ٝكطؽ زٕٛٞ اُسّ ٝاضرلبع اُؽٔ٘خ شُي ك٢ اُسٓٞ٣خ ثٔب
اُؽٌط١. ٓطػ٠ ث٤ٖ ٝالإػبهخ أُجٌطح اُٞكبح ك٢ اُسٓٞ٣خ ٝرزؽجت ٝالأٝػ٤خاُوِت 
ٛسف اُسضاؼخ :
 ػـؾ اضرلبع شُي ك٢ اُسٓٞ٣خ ،ثٔب الأٝػ٤خاُوِت ٝ لأٓطاعاُرطٞضح أُؽججخ  ػٞآَ اٗزشبض ٓسٟ رحس٣س
 اُسّ
ٓطع  ٣ؼبٕٖٗٞ اُص٣ أُطػ٠ ث٤ٖ ،كطؽ زٕٛٞ اُسّ ٝاُزسذ٤ٖ اُجسٗ٢ اٗؼساّ اُ٘شبؽ أٝ،هِخ  اُؽٔ٘خ
 ُحْ. ث٤ذ طحخ ٓس٣ط٣خ ك٢ اُؽٌط١ ػ٤بزاد اُؽٌط١ اُ٘ٞع اُضبٗ٢ ك٢
أُٜ٘غ٤خ : 
 اُؽٌط١ ُٔطػ٠ ػ٤بزاد 5ك٢  أعط٣ذ ؽجو٤خ ػشٞائ٤خ ػ٤٘خ ذلاٍ ٖٓ ٓؽزؼطػخ ٓوطؼ٤خ زضاؼخ ٛصٙ
.6102ٗٞكٔجط  إُ٠ ٣ٞٗ٤ٞ ٖٓ اُلزطح ك٢ 332ُِٔشبضً٤ٖ  الإعٔبُ٢ اُؼسز اُظحخ. ًبٕ ٝظاضح ك٢
اُ٘زبئظ :
 ٪34ٓضِذ  ٝاُز٢ اُسٓٞ٣خ ٝالأٝػ٤خ اُوِت ثأٓطاعا أط٤جٞ ٓشبضًب   332ٖٓ  001إٔ  اُ٘زبئظ أظٜطد
ٓؼسٍ اٗزشبض  ًبٕ ُس٣ْٜ ٌُٖٝ اُسٓٞ٣خ ٝالأٝػ٤خ اُوِت ثأٓطاعٖ ٓظبث٤ ٣ٌٞٗٞا كِْ اُجبهٕٞ اُؼ٤٘خ،أٓب ٖٓ
اُسٓٞ٣خ . ٝالأٝػ٤خاُوِت  لأٓطاعػبُ٢ ُؼٞآَ اُرطٞضح 
ٓط٣غ: 331اُسٓٞ٣خ ث٤ٖ  ٝالأٝػ٤خاُوِت  لأٓطاع اُرطٞضح ػٞآَ اٗزشبض ٓؼسٍ
 )  ٓغ اُغ٘سض ح٤ش1000. = pٝاُؽٔ٘خ  ( ٌُُٞؽزطٍٝا ٖٓ ًَ ك٢ إحظبئ٤خزلاُخ  ٝهس اػٜطد اُ٘زبئظ ,
إٔ أذطٟ ٗزبئظ اُزٞاُ٢ .ٝأظٜطد ٪ ػِ٠38٪ ٝ 2.08ث٘ؽجخ  اُصًٞض ٖٓ أػِ٠ ٓؼسٍ الإٗبس أظٜطد
. %3.32ٖٓ ذٔػ أُشبضً٤ٖ ٣ؼبٕٗٞ ٖٓ ظ٣بزح ك٢ اُٞظٕ  أًضط حٞاُ٢
IV
 ٓزٞؼؾ ٪ ًٝبٕ 5.68ث٘ؽجخ  ٞضح الأذطٟاُرط ػٞآَ ث٤ٖ اٗزشبض ٓؼسٍ اٗؼساّ اُ٘شبؽ اُجسٗ٢ أػِ٠ ًبٕ
 = P(  اُغ٘سض ) ،100.0 = Pاُؼٔط ( ٝعٞز زلاُخ إحظبئ٤خ ٓغ ٓغ ؼبػخ 3.3±  1.21اُرٍٔٞ اُجسٗ٢ 
)500. = pاُؽٌط١ ( ٓطع ) ٝٓسح220.
زلالاد إحظبئ٤خ  ٝعٞز ػسّ ٓغ  2.66أُشبضً٤ٖ ث٘ؽجخ % ٪ ث٤ٖ 2.66ك٢  اُسّ ػـؾ اضرلبع ُٞحع
اُحبُ٤٤ٖ. ٪ ث٤ٖ أُسذ٘٤ٖ 8.6ث٘ؽجخ  اٗزشبض ٓؼسٍ أهَ اُزسذ٤ٖ ًٝبٕ
)1000.=p(اُسضاؼخ ٝعٞز زلاُخ إحظبئ٤خ ث٤ٖ  اُؼٔط ٝذطط الإطبثخ ثٔطع اُوِت اُزبع٢  اظٜطًٔب 
) ٝ 1000.=pث٤٘ٔب اُؽٌزخ اُسٓبؿ٤خ ًبٗذ ُٜب زلاُخ إحظبئ٤خ ٓغ اُؼٔط ٝٓسح الإطبثخ ثبُؽٌط١(
 ) ػِ٠ اُزٞاُ٢ .100.=p(
 ) ٝٗلػ400 = Pاُغ٘سض  ( ٓغ ٌُُِٞؽزطٍٝٝعٞز زلاُخ إحظبئ٤خ  اُ٘زبئظ اُسٕٛٞ،أظٜطد رحِ٤َ ٓغ
ُِصًٞض. أػِ٠ ٓؼسلاد الإٗبس أظٜطد) ح٤ش 200. = Pاُضلاص٤خ ( ُِسٕٛٞ ثبُ٘ؽجخ اُش٢ء
اُرلاطخ :
 اُع٣بزح ٛصٙ إُ٠  رسكغ اُز٢ اُؼٞآَ ٖٓ ٝعٞز اُؼس٣س ٓغ كِؽط٤ٖ، ؼ٘ٞ٣ب ك٢ ُؽٌط١ا ٓطع ػسز ٣زعا٣س
 اُؽٌط١ ُٔطع أُجٌط ٝالاًزشبف اُزحط١ إٕ اُؽٔ٘خ. إُ٠ ثبلإػبكخ ٝاُزحؼط اُح٤بح ٗٔؾ رـ٤٤طَ ،ٓض
ثبُٔطع  الإطبثخٓؼسلاد  ٝاُزوِ٤َ ٖٓ اُؽٌط١ ثٔطع  اُغس٣سح  الإطبثخ حبلاد ُِزوِ٤َ ػِ٠ ػطٝض١
 اُرطٞضح الأذطٟ ػٞآَٓطاهجخ ٝػجؾ ػلاٝح ػِ٠ شُي اُسٓٞ٣خ .  ٝالأٝػ٤خاُوِت  ثأٓطاعٝاُٞك٤بد  
 رؤذط  ظٜٞض أٝروَِ   إٖٔٓ شبٜٗب  اُلؼبٍ اُؼلاط رٞك٤ط ذلاٍ اُسٓٞ٣خ ٖٓ ٝالأٝػ٤خ اُوِت لأٓطاع
اُسٓٞ٣خ. ٝالأٝػ٤خاُوِت  أٓطاع
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Chapter One 
 
Introduction 
1.1 Background 
Non communicable disease (NCDs) or chronic diseases (CD) are the leading 
cause for death worldwide according to the World Health Organization 
(WHO).Globally, two thirds of deaths were caused by NCD in 2010 where 
cardiovascular disease (ischemic heart and stroke) was the major killer among 
other NCDs such as cancer and diabetes (WHO,2010).As a point of fact, and 
according to the findings of the WHO in 2010,low and middle income 
countries have about 80% of NCDs deaths. This may be an indicator for the 
increased morbidity, disability and mortality rates among people in these 
countries, which ultimately requires from their  governments to adopt long-
term strategic policies to curb the increase in  these diseases and risk factors 
that cause them. 
There are four behavioral risk factors that contribute to NCD. Those factors , 
tobacco use, physical inactivity, unhealthy diet and alcohol consumption 
(WHO, 2010). These risk factors can be reduced or controlled by preventative 
measures and changes in life style. Other minor risk factors which cannot be 
reduced or modified and can cause NCDs include age, gender, family history 
and race.  
Burden of NCDs 
According to the WHO’s global status report on non-communicable 
diseases,56 million people died in 2014, 38 million (68%) of whom died due to 
NCDs (cardiovascular disease, cancers, diabetes and chronic respiratory 
disease)and 16 million (40%) of  all NCD deaths were under the age of 70 
years old. About 28 million of cases represent three quarters of all NCD deaths, 
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and 82 % of premature deaths occur in low- and middle-income 
countries.(WHO, 2014). 
More than 80% of cardiovascular diseases and diabetes deaths , in addition, to 
90% of  deaths from  chronic obstructive pulmonary diseases occurred in low 
and middle income countries(WHO, 2010). 
Burden of NCDs in Palestine 
According to the WHO , 74.9% of all deaths in the West Bank are due to NCDs 
which CVD represented the highest percentage by 44.2% followed by cancer 
18.3%and diabetes mellitus 1.2% .(WHO,2015). 
Ministry of Health (MoH)detected the major causes of death in Palestine in 
2016 that CVD still the major cause of deaths with 30.6%, cancer was the 
second leading cause with 14% ,Cerebrovascular diseases were the third 
leading cause of death with 12.8% , diabetes and its complications are parallel 
with prenatal period that came in the forth rank by 8% followed by Respiratory 
diseases as six cause of death  with 6.3% .(MoH , 2016)  
According to the study done by Badran and Laher (2011), Arabic-speaking 
countries are experiencing an increase in chronic diseases with variations 
between them related to the different income rates and life style. 
 
Burden of NCDs on Economy: 
Chronic  diseases  such as  cardiovascular diseases, diabetes and cancers are  
exhausting the budgets and resources of health systems in both developed and 
developing countries.  
In the same context,  the world is experiencing fundamental changes in lifestyle 
with a clear decline in middle-class layer in the society  , which is increasing 
the class inequality among people leaving poverty and further risk factors for 
diseases . 
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This will increase the risk  of having one or more of NCDs that could have a 
negative impact on the economic, political  and social contexts for communities  
According to the American Diabetes Association(ADA)(2013),the total direct 
and indirect cost of DM was $245 billion in United States of America ( USA)in 
2012. 
The Robert Wood Johnson Foundation (2006) reports that 84% of all health 
care spending in USA in  2006 was for people who have one or more chronic 
disease .Also in USA, in 2010  the total cost of heart disease and stroke were $ 
315.4 billion (American Heart Association(AHA), 2014). 
In European countries, the health care expenditure was  € 110 billion (10%) of 
the total annual cost of EU economy. For example, diabetes disease type 2 
affected 10% of the adults populations in Europe and cost €166 billion annually 
which represents more than 10% of the European health budget (International 
Diabetes Federation(IDF),2006). 
Cumulative economic losses to low and middle income countries (LMICs) 
from the four diseases are estimated to surpass US$ 7 trillion over the period 
2011-2025 (an average of nearly US$ 500 billion per year).On a per-person 
basis, the annual losses amount to an average of US $25 in low-income 
countries, US$ 50 in lower middle-income countries and US$ 139 in upper 
middle-income countries (WHO, 2013, p5. ). 
According to the  Palestinian Central Bureau of Statistics the health 
expenditure is about 11%  from the Gross Domestic Product (GDP) in 
2014with a slight difference compared to the year 2013 which was 10.9% 
(PCBS,2014). 
Total expenditure on the health sector in 2015 was US $1.321,3 million  
compared with US $1.243.2 million  in 2014 and the total expenditure per 
capita on health was US $ 282.2$ in 2015 compared to US $ 271.2 in 2014. 
(PCBS,2015) . 
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In 2012, 82 percent of all public expenditures on health  in Palestinian 
Authority were allocated to curative care, while only 14 percent went towards 
preventative care and public health services; 66 percent of curative care 
expenditures were for inpatient care and 34 percent for outpatient care (World 
Bank, 2016,P.37).  
1.2 Diabetes Mellitus: 
The global burden of diabetes mellitus (DM) is rising dramatically and  
constitutes a major public health challenge for developed and developing 
countries. The International Diabetes Federation (2010) reports that there are 
422 million (8.5%) people who have diabetes worldwide. More than 80% of 
people with diabetes live in low and middle income countries. Of whom, 
socially and economically disadvantaged people bear the greatest burden of 
disease and the most affected financially(International Diabetes Federation, 
2013).Diabetes is rising globally and it is expected to reach 471 million 
affected individual in 2035 increasing the rate by55%. In 2013  diabetes killed 
5.1 million people and the world health expenditure was 548 billion dollars 
(11%) of the total spent worldwide in that year(International Diabetes 
Federation, 2013). 
Burden of diabetes in Palestine  
Diabetes mellitus in Palestine is rising dramatically as the rest of the world 
.The prevalence of this disease was 11.5% in 2000 and increased to 14.5% in 
2010 with forecasts to reach 20.8% in 2020 and 23.4% in 2030 .(Abu-Rmeileh 
et al ,2013) 
1.2.1  Diabetes definition : 
Diabetes Mellitus (DM) is a general term for heterogeneous disturbances  in 
metabolism characterized by hyperglycemia(Kerner & Brückel, 2014). 
There are three types of diabetes: type 1, type 2 and gestational diabetes . 
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 Type 1 diabetes: 
Also called insulin-dependent and it is considered as an autoimmune disease 
affecting  pancreatic B cells which lead to absolute insulin deficiency(Kerner & 
Brückel, 2014). 
 Type 2 diabetes: 
It is the most common form of diabetes known as insulin resistance whereby 
the pancreases cannot produce enough insulin or the body cannot use insulin 
well enough and this condition is called  non-insulin dependent (Kerner & 
Brückel, 2014).  
 Gestational diabetes:  
This condition appears during pregnancy and can lead to serious health 
problems for mother and her infant by increase their risk to develop type 2 
diabetes in their future(Kerner & Brückel, 2014). 
All these types can cause damage for body organs such as the kidneys, eyes, 
feet, bones and heart which lead to early death (WHO, 2016).  
1.2.2  Prevalence of diabetes:  
The prevalence of diabetes is different  from region to another . According to 
Chan et al. (2014), the Western Pacific region forms the highest prevalence of 
diabetes  by 138 million  and the Africa region is the smallest by 19.8 million 
.In the Middle East and North Africa, the number reached 34.6 million in 
2013.Those regions are different in their expenditure and management for 
diabetes, which affects  the health status of patients and the ability of health 
systems to develop the necessary policies for disease prevention. 
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Diabetes forms one of the major chronic diseases in the Arab countries and the 
gulf countries have the highest prevalence. As a point of fact, Saudi Arabia, 
Qatar, and Kuwait have the highest prevalence by 24%,23% and 23% 
respectively (International Diabetes Federation,2013).   
1.2.3  Diabetes complications and cardiovascular disease: 
Some people who've had type 2 diabetes for a long time may not show any 
symptoms despite elevated blood sugars. They consequently expose their 
bodies for damage as a result of hyperglycemia and are at high risk to develop 
complications (International Diabetes Federation,2013). 
Diabetes Mellitus can have an impact on a wide verity parts of the body 
including the eyes, kidneys, nerves, feet and heart. People with diabetes have 
high rates of obesity, dyslipidemia, high blood pressure and physical inactivity 
which are considered as risk factors for cardiovascular disease (CVD) and 
other health problems (WHO,2013). 
With that being said, and as per the global status report of the WHO in 2013, 
diabetes mellitus is considered one of the major causes for cardiovascular 
diseases  including ischemic heart disease , cerebrovascular disease (stroke) , 
peripheral vascular disease, congestive heart failure and myocardial  infarction 
(MI)that lead to early death among people with diabetes. CVD is considered 
the main killer disease among diabetic patients as approximately 65%-80% of 
people with diabetes die from CVD in developing countries (WHO, 2013). 
Although our study deals with risk factors for CVD  , we have not neglected 
the effect of HbA1c of increased risk of CVD . 
Patients with diabetes should have to keep HbA1c around 7% in blood to 
maintain their health and eliminate complications which increase the risk for 
CVD . HbA1c reflects the average blood glucose level over 12-14 weeks of 
red blood cells (RBC) lifespan  . 
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 WHO approved guidelines to diagnose Type 2 DM is represented by using 
glycated hemoglobin test (HbA1c) . That HbA1c can indicate whether an 
individual is normal , pre-diabetic or diabetic according to the following 
parameters: 
Below 6% is considered normal , 6% to 6.4% pre-diabetes and 6.5% or more 
is diabetes. 
It is considered as an indicator to glucose control and gives a good estimate 
about the prognosis of the disease and is therefore adopted as screening test 
diabetes (Global Diabetes Community,2009).  
The American Diabetes Association (2009) recommend keepingHbA1c< 7% 
to have controlled glucose and eliminate the diabetes complications in the 
future (Monnier& Colette, 2009).  
1.3Cardiovascular disease (CVD): 
Non-communicable diseases (NCDs) are considered the leading cause of death 
globally. Approximately 56 million people died in 2015,39.5million (70%) of 
whom were due to NCDs, mainly  CVD, cancer ,diabetes and chronic lung 
disease as reported by the WHO, 2016). 
Approximately , 30  million deaths (70%) of NCDs  occurred in low and 
middle income countries and most of these deaths occurring before the age of 
70.CVD were the first cause of death  by 17.7 million (45%), cancers were the 
second cause by 8.8 million (8.8%) and other types of NCDs deaths had a share 
of 22% (WHO, 2017).  
Patients with diabetes type 2 are at high risk of developing one or more CVD in 
the future including stroke, coronary heart disease , congestive heart failure and 
many others. 
The incidence of CVD among patients with diabetes type 2 is increasing  for 
many reasons .Those include advancing age which represents as a risk factor 
for CVD and  insulin treatment and improved medical care that prolongs their 
lives and delays or prevents complications of diabetes(WHO, 2017). 
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1.3.1Types of cardiovascular disease (CVD): 
Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood 
vessels and they include. CVD that accompany diabetes include heart attack 
(myocardial infarction MI), stroke, peripheral artery disease, congestive heart 
failure and angina (International Diabetes Federation,2010).  
 Stroke  
A stroke is similar to a heart attack but it occurs in the brain depriving it from 
oxygen and nutrients (Mayo Clinic, 2017).  
 Atherosclerosis  
Is a condition that develops when plaque builds up in the walls of arteries 
preventing blood flow to the heart which leads to a heart attack or stroke 
(American Heart Association, 2017). 
 Heart attack (HA): 
Is a condition that occurs when blood supply to the heart muscle is stopped or 
severely reduced, which causes death or damage to part of the heart muscle.  
 Congestive heart failure (CHF) : 
Also called heart failure, defined as the inability of the heart to provide 
efficient blood flow to other organs and this disease is caused by many 
conditions such as heart attack, failure of the ventricles and hypertension 
(Medicine Net, Inc. 2017).  
 Peripheral artery disease (PAD) : 
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A reduction of blood supply in the body extremities particularly occurs in the 
legs as a result of the accumulation of fatty deposits in the arteries of the leg 
(Mayo Clinic, 2017). 
 
1.3.2Cardiovascular Risk Factors: 
There is no doubt that preventative measures to reduce and control risk factors 
(RFs) for CVD could lower mortality and disability rates among people with 
diabetes 
Addressing Behavioral risk factors such as smoking , unhealthy diet , physical 
inactivity ,obesity and harmful use of alcohol by a adopt long term strategies 
aims to delay or eliminate CVD .One of these strategies is Best buys or cost 
effectiveness which can adopted and implemented even in low resource setting 
.WHO determined two approaches of intervention : population -wide and 
individual intervention .population –wide strategies including  high taxes on 
tobacco industry  and foods   that are rich in sugars ,fats and salt .Adopt 
comprehensive policies to curb smoking by prohibition of smoking in public 
areas and enforcing laws that criminalize the sale of tobacco  to children and 
adolescents .Moreover enabling people to exercise by providing places to walk 
and practice and provide healthy meals for students in schools .  
At the individual level it is important to assess the risk factors of CVD such 
as dyslipidemia  and hypertension , in addition to the presence of diseases 
including  DM and provide  an effective treatment with aspirin ,beta-blockers 
and statins. ( WHO, 2017) .  
In this study, the focus will be on modified cardiovascular risk factors that are 
associated with diabetes: hypertension, obesity , dyslipidemia, smoking and 
physical inactivity. 
 
 Hypertension :  
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Hypertension (HTN) or high blood pressure, sometimes called arterial 
hypertension, is a chronic medical condition in which the force of the blood 
pushing against the artery walls can cause health problems on the long run 
(Mayo Foundation for Medical Education and Research,2017). 
 
Blood pressure is summarized by two measurements, systolic and diastolic, 
which depend on whether the heart muscle is contracting (systole) or relaxed 
between beats (diastole). This equals the maximum and minimum pressure, 
respectively (American Heart Association,2016).  
 
The American Heart Association(AHA) categorized blood pressure into five 
categories as shown below (2008): 
 
Blood pressure category Systolic(mmHg) Diastolic(mmHg) 
Normal  < 120 < 80 
Pre-hypertension 120 -139 80 - 89 
High blood pressure (stage 
1) 
140 – 159 90 - 99 
High blood pressure (stage 
2) 
≥ 160 ≥ 100 
Hypertensive crisis (need 
emergency care) .  
≥ 180 ≥ 110 
 
 Over weight and Obesity : 
 
WHO (2013) defines obesity and overweight as abnormal or excessive 
fat accumulation that may cause health problems, and are measured by 
the body mass index (BMI). The body mass index (BMI) is a simple 
index of weight-for-height that is commonly used to classify overweight 
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and obesity in adults. It is defined as a person's weight in kilograms 
divided by the square of his height in meters (kg/m
2
). 
Normal weight is defined as a BMI 18 to 24.9 kg/m
2 , 
overweight 25 to 
29.9 kg/m
2
 and obesity as BMI >= 30 kg/m
2
(Pischonet al. 2008). 
 
 Dyslipidemia : 
 
A disorder of lipoprotein metabolism, including lipoprotein 
overproduction or deficiency. Dyslipidemia  may be manifested by 
elevation of the total cholesterol the "bad" low-density lipoprotein 
(LDL) cholesterol and the triglyceride concentrations, and a decrease in 
the "good" high-density lipoprotein (HDL) cholesterol concentration in 
the blood. (Medical Dictionaries,2014). 
  
 Smoking: 
Smoking is the inhalation of the smoke of burning tobacco encased in 
cigarettes, pipes, and cigars(Medical Dictionaries , 2014). 
 
 Physical Inactivity : 
The WHO defines  physical activity as "any bodily movement 
produced by skeletal muscles that requires energy expenditure – 
including activities undertaken while working, playing, carrying out 
household chores, travelling, and engaging in recreational 
pursuits"(WHO, 2017). 
 
 Sedentary Lifestyle : 
            It is defined as "The a type of lifestyle where an individual does not 
receive regular amount of physical activity " (WHO, April 2002) . 
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1.4  Health status in Palestine: 
Palestinians are clearly living in difficult and unstable economic conditions that 
are indirectly reflected on their life style and health status. Approximately 
25.8% of Palestinians live in poverty (17.8% in the West Bank and 38.8% in 
the Gaza Strip) and living on a monthly income of $637(Palestinian Central 
Bureau of Statistics,2014).  
Also  Israeli occupation is one of the main factors that threaten the lives of 
Palestinians not because it causes death , injury and disability , but also because 
the occupation promotes discrimination and segregation and marginalization, 
which reduces the chances of the Palestinians to live in dignity and 
accessibility to public services, including health services (The Lancet, 2009). 
In addition to the internal Palestinian division between Fatah and Hamas, 
which created two governments one in  West Bank and the other in the Gaza 
Strip, where this division strengthened fragmentation in the Palestinian 
situation, including of course the health system (Ashoor,2010).  
According to the Palestinian Central Bureau  of Statistics   "The contribution of 
the household sector to total expenditure was 40.9% in 2010 and 43.1% in 
2011, while Contributions by the governmental sector (through the Ministries 
of Finance and Health) were 35.3% in 2011. These numbers indicate the 
burden of health expenditure on the Palestinians' life and threatens their right 
and ability to access proper health care when needed . 
Another challenge is the fragmented and weak healthcare system and its 
inability to meet the growing needs and demands that contribute to increasing 
the burden of NCDs and risk factors. 
 
1.5 Health Care System: 
The health system is the combined entity of all resources, actors and 
institutions related to the financing, regulation and provision of all activities 
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whose primary intent is to improve or maintain health .The health system is 
made up of fragmented services that are supplied across different providers 
including Ministry of Health (MoH),   United Nation Relief and Work Agency 
(UNRWA), Non-Governmental Organizations (NGOs)and for profit private 
sector. 
The Ministry of Health is the largest provider of services, but some of these 
services may be not adequate for needs of the people, especially in tertiary. 
Therefore, the MoH refers patients to different destinations (Jordan , Israel , 
Egypt and local health  NGOs).  
In this context, the Ministry of Health has made a great and significant effort to 
reduce the cost of purchasing the service in general from abroad and from 
Israel in particular, by reorganizing all procedures and policies, establishing 
protocols and concluding agreements with the Israeli side, training health 
personnel and providing services through enabling hospitals with equipment, 
physicians with a rare specialty and building specialized hospitals . 
The cost of referrals services to Israeli hospitals declined by 32% in the second 
half of 2015, less than the same period in 2014. This decline continued in 2016 
with 27% less than the same period in 2015 (Bitar, 2016). 
On the same hand, the Ministry of Health is seeking to adopt and develop 
health policies aimed to reducing or minimizing the burden of chronic diseases 
through early detection of injury, and monitoring of the risk factors that lead to 
injury by CD. 
One of these polices is implemented in  their  primary health care is known as  
Package of Essential Non-communicable (PEN) Disease intervention for 
primary health care (Pin Approach) in Low-Resource Settings. 
 
Palestine was chosen by the WHO to implement this trial concerned with the 
major NCDs such as heart disease and stroke, cancers, diabetes and  chronic 
respiratory disease that are leading to death worldwide .Through this  
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prevention policy, the WHO seeks to strengthen equity and efficiency of health 
systems in low and middle income countries (WHO, 2010).  
 
1.6  Problem statement: 
The incidence of diabetes mellitus (DM) is rising among Palestinians which 
indicates an increased burden of this disease and additional numbers of 
individuals affected by it and its related complications in the near future .In  
Gaza strip, the incidence rate for diabetes were 178.3 per 100,000 in 2016  and 
in West Bank the incidence rate for men was 174.6 per 100,000 and 211.5 per 
100,000 in women .(MOH, 2017) 
Furthermore, a reasonably large number of diabetic patients may have one or 
more risk factors for CVD and others are diagnosed previously by CVD as a 
result of diabetes complications (National Diabetes Education Program, 2007). 
 
Efforts towards reducing  or preventing injury by CVD among diabetic patients 
do not seem to be effective and the policies carried out by the Palestinian 
Ministry of Health (MoH) and other health organizations need to be assessed. 
According to the WHO, 17.7 million of people were died from CVD which 
represented 31% of all total deaths .Coronary heart disease (CHD) has been 
issued with 7.4 million of deaths while the number of deaths from stroke was 
6.7 million Low –and middle income countries have the largest share of NCDs 
deaths with 82% and  37% of these deaths caused by CVD in 2015. (WHO , 
2017) 
As a result of CVD and are hence causing more challenges for the health 
system in terms of social and economic burdens.   
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1.7  Study justification: 
The burden of CVD is high and expensive and DM is considered an 
independent risk factor for CVD thereby requiring actual intervention by health 
care system and the community. 
CVD is the first cause of death among Palestinians by 30.6%% and diabetes is 
the fourth  reason for death by 8% as a result of its complications which could 
be CVD or other diseases(Ministry of Health , 2016). 
Therefore, early detection of risk factors for CVD and controlling blood 
glucose levels among diabetic patients could improve their health and avoid 
early onset of CVD and other health problems. 
Health is a right for all. Diabetic patients need not only to receive treatment but 
also to be more aware and responsible about their disease. Until recently, there 
are still patients who deny or are careless about their disease. This attitude 
unfortunately accelerates early risk factors for CVD.  
Therefore, early detection  and prevention of risk factors for CVD among 
diabetic patients has to be a fundamental priority for the Palestinian Ministry of 
Health.      
 
 
 
1.8 Aim of the study: 
This study aims to determine the prevalence of modifiable cardiovascular risk 
factors including hypertension, obesity, physical inactivity and, smoking, 
among patients with Type 2 DM at diabetic clinics in the Bethlehem health 
directorate. 
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1.9 Objectives 
To assess the prevalence rate of risk factors of CVD among insulin dependent 
patients type 2 patients and to examine  the relationship between these risk 
factors and the risk of having  CVD. 
 
1.10 Limitations of the study: 
1- Despite the fact that the waist circumference parameter is essential, it 
will not be considered because it was not applied in all clinics. 
2- There was an unreal  increase in the records numbers of diabetic 
patients in the central diabetic clinic in the  Directorate due to the 
lack of updating these records for a long time which we had to 
renewal the records with the help of the nurse. 
3- Documentation in Patients' records were particularly not complete 
regarding the progression of disease, change of treatment or the 
addition of other treatments and the onset of disease . Physician Only 
reported any complications or changes  as notes in the form of drug 
prescription despite the existence of the form. This issue will 
indirectly affect the follow-up of patients and the monitoring the 
progression of DM. 
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Chapter Two 
 
Literature Review 
 
Introduction  
 
This chapter presents  information about modified CVD risk factors among 
diabetic patients  and the previous studies which is related to including local , 
regional and international studies .Moreover, information about  uncontrolled 
HbA1cand its association with CVD are presented. 
 
2.1  Risk Factors related to the risk of CVD  among diabetic patients 
 
International Studies  
2.1.1 Hypertension : 
Hypertension (HTN) or high blood pressure, sometimes called arterial 
hypertension, is a chronic medical condition defined as force of the blood 
against artery walls. Blood pressure is summarized by two measurements, 
systolic and diastolic , which depend on whether the heart muscle is contracting 
(systole) or relaxed between beats (diastole). This equals the maximum and 
minimum pressure, respectively. Blood pressure  is measured in millimeters of 
mercury (mm Hg) (Mayo Foundation for Medical Education and Research, 
2017, P.1) . 
Most people who have hypertension  have no symptoms which is the reason for 
it being called silent killer. The Centers for Disease Control and Prevention 
(2017) state that late diagnosis of high blood pressure increases the risk of 
stroke , heart attack, congestive heart failure and other diseases. The regular 
measurement for blood pressure can achieve early detection and delay or 
prevent other complications in the future. 
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There are many factors that, combined together, cause hypertension and 
develop complications as social detriments (urbanization , globalization, aging, 
income, education level and housing). These factors can be accompanied by 
some behavioral risk factors such as physical inactivity, unhealthy diet, 
smoking, stress and harm use of alcohol.  
 
Globally more than 1 in 5 adults have hypertension .It is responsible for half of 
all deaths from stroke and heart disease (HD). Also complications of raised 
blood pressure caused 9.4 million deaths worldwide every year. The highest 
prevalence of hypertension was in African region at 30% and the lowest rate 
was in America at 18% in 2014 (WHO, 2015). 
 
In Palestine , few studies have been conducted to determine the prevalence rate 
of HBP , one of these studies was carried out in West Bank in 2011.  
The study targeted 2077 of adults older than 25 years in six governmental 
primary health care clinics in Hebron , Ramalla and Nablus .women 
represented 58% of the total participation .Results showed high prevalence rate 
among Palestinians by 28% (Lancet ,2013) . 
 
 
Many studies were carried out about hypertension among patients with type 2 
DM .Three cross-sectional studies were conducted in Nigeria, Jordan and 
Morocco in 2004, 2006 and 2006 respectively. 
These studies aimed to detect the prevalence of HTN among patients with type 
2 diabetes and to detect risk factors, level of awareness and control of HTN 
among Type 2 DM. Their findings showed a high prevalence of HTN by 58.9% 
in Nigeria, 72.4% in Jordan and 70.4% in Morocco .All three studies showed a 
significant statistical difference between males and females, where in Jordan, 
the rate was 70.9% for men and 73.9% for women. Morocco scored the same 
rate for both men and women (31%). Whereas in Nigeria, men had the highest 
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rate by 50.8% compared to women by 49.2% . (Unadikeet al. 2004, Mubarak et 
al. 2006,  Berrahoet al. 2006). 
A famous Framingham Study done by Delany (2009) which has been carried 
out for44 years concluded that there was a relationship between the BMI which 
included overweight and obesity and high blood pressure .The author 
concluded that overweight and obesity accounted by 26 % of cases of 
hypertension in men and 28% in women and cases of CHD by 23% for men 
and 15% for women . 
 
2.1.2  Overweight and Obesity: 
Overweight and Obesity have represented a real challenge for public health 
both clinically and economically worldwide (Lavieet al., 2009). Globally, 
overweight and obesity are increasing dramatically and the obesity increased 
more than double since 1980 (WHO,2015).The prevalence of overweight 
individuals was 39% (1.9 billion adults) and 13% (600 million) were obese in 
2014.  
The burden of  obesity is large and complicated and may be causing significant 
health problems including CVD, diabetes, bone disease, hypertension, 
dyslipidemia and other problems (Lavieet al., 2009).That is in addition to the 
social problems from which obese individuals suffer .Some of these problems 
exemplify as shame from others, stress and may be treated with bias. 
Therefore, WHO considered obesity as an epidemic disease and has committed 
many programs aimed to prevent and manage the consequences of obesity . 
These alarming figures and others represent a real danger and a threat to 
communities as they are increasing health problems which in turn mean more 
expenditures, mortality, morbidity and disability. Accordingly, it is necessary 
to have a national program which aims to bring a change in life style and 
prevention against obesity  
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Clinically, obesity is playing a significant role in developing insulin resistance 
and glucose intolerance and these metabolic factors considered as major cause 
of onset of diabetes type 2 and CVD (American Heart Association, 2004).Also 
it has adverse effects on the structure and function of the cardiovascular system 
leading  the onset of other health problems and serious heart diseases such as 
heart failure (HF) and coronary heart disease (Arthamet al., 2009). 
Measuring of Weight: 
There are many indices that are used to detect obesity and abnormal adiposity 
such as the BMI, body fatness, waist circumference (WC), waist-to-hip ratio 
(WHR) and  weight-to-height ratio (Litwin, 2008).   
Many studies were conducted about obesity and its association with DM and 
CVD . 
A cohort study entitled ―Body Mass Index and Heart Failure Among Patients 
with Type 2 Diabetes‖ was conducted by Louisiana State University Hospital 
with the aim to examine the association between BMI and the risk of incident 
HF among patients with type 2 diabetes. A total of 31155 patients with type 2 
diabetes were included in the study (36.8% men and 63.1% women) aged 
between30-94 years with a mean follow–up of 7.8 years. Their findings 
showed a positive association between BMI and the incident of HF among 
participants. 5834 of patients(18.7%) developed HF among men and women 
(40.8%, 59.2%) respectively .There was also a significant increased risk of HF 
among men with a BMI ≥30 kg/m2 and among women with a BMI ≥30 and 
18.5 to 22.9 kg/m
2
, compared with those with a BMI of 25 to 29.9 
kg/m
2
(Weiqinet al., 2010). 
 
Another cohort study in the Swedish National Diabetes Register investigated 
the associations of BMI, overweight (BMI 25–29.9 kg/m2) and obesity 
(BMI ≥ 30 kg/m2) with cardiovascular disease in type 2 diabetes. The total 
number of participants was 13,080 with an age category of 30-74 years with no 
previous CHD or stroke. Patients were followed for a mean of 5.6 years until 
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2003. The authors concluded that there is a statistical significant relationship 
between the incidence of overweight and obesity and the incidence of 
cardiovascular disease. 
The results showed that increasing of 5 units in BMI at baseline will give a 
relative risks of stroke (11%), CHD (15%), cardiovascular disease (13%) and a 
total mortality rate of 27% (Eeg-Olofssonet al., 2013). 
 
A descriptive study took place in the United Kingdom in 2006 whose objective 
was to determine the prevalence of overweight and obesity among diabetic 
patients (Type 1, Type 2). The authors studied the effect of overweight and 
obesity on other CVD risk factors including uncontrolled glucose, lipid profile 
and blood pressure .The study shows information on 3637 patients (916 type 1 
and 2721type 2) who attended secondary diabetic care clinics. The findings 
showed a high prevalence of overweight by 86% and obesityby52% among 
patients with type 2 diabetes compared to patients with type 1diabetesby 55.3% 
were overweight and 16.6% were obese. Also, patients with type 2 diabetes had 
hyper pressure, higher level of HbA1c and worse lipids when compared to 
other groups(Daousiet al., 2006). 
2.1.3  Dyslipidemia:  
Dyslipidemia is classified into two categories: Primary refers to genetic 
disorders or defects that affect the metabolism of lipoprotein directly, and 
secondary as a result of other diseases that affect the metabolism of lipoprotein 
indirectly such as DM, autoimmune diseases, hypothyroidism, sepsis ,liver 
disease and chronic renal insufficiency (CRI).(Elsevier,2010) . 
According to the Centers for Disease Control and Prevention, 31million adults 
in the United States have total cholesterol levels that exceed 240 mg/dL. The 
risk for CVD injury among people with high total cholesterol has twice 
compared to people with total cholesterol less than 200 mg/dL. Also ,73.3 
million adults (31.7)  have elevation level of low density lipoprotein (LDL)or 
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what is known as bad cholesterol and about 48% of adults with high LDL 
cholesterol are treated with lipid lowering therapy (Mozaffarian et al., 2014). 
Dyslipidemia considered as one of the major risk factor for CVD among 
T2DM. With diabetic patients type 2 this condition occurs as a result of insulin 
resistance or deficiency which affects key enzymes and pathways in lipid 
metabolism(Taskinen, 2002). 
Mathew et al. (2009) investigated the records of 294 patients with type- 2 DM 
who attended two hospitals (private & governmental) in Northern Emirates, the 
age group of40-59 years (49%). Only 32% had controlled glucose levels. 8.6% 
of the study subjects did not have HTN or Dyslipidemia (DL)  and the majority 
(88%) had HTN and 69.6% had Dyslipidemia and 66.1 % had both. 
The authors concluded that there was a significant association between age and 
DL, and nationality and DL, but not with HTN. These findings showed a high 
percentage of three conditions (DL, HTN and uncontrolled glucose) 
emphasizes the importance of working to control and eliminate these 
conditions in order to delay or  prevent the risk of CVD (Mathew et al., 2009). 
Yet another cross sectional study carried out in India among 50 newly 
diagnosed  type 2 diabetic patients between the period of March 2013 and 
October 2014with the aim to detect the prevalence and pattern of dyslipidemia 
in type 2 diabetes mellitus patients attending the Rural Health and Training 
Centre of medical college in Bhopal, 
 Madhya Pradesh. The results indicated a high prevalence of dyslipidemia in 
43(86%) participants. High total cholesterol with increased LDL, cholesterol 
and triglycerides was detected in 18 (36%), 33 (66%) and 32 (64%) of 
participants, respectively. The results also showed decreased HDL cholesterol 
in 26 (52%) study subjects. Furthermore, the study observed that the most 
common pattern of dyslipidemia was mixed (more than two parameters of 
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dyslipidemia) and this might lead to developing one or more cardiovascular or 
cerebrovascular diseases (Amodet al. 2014). 
On the same note, a cross sectional study was conducted among 295 diabetic 
patients in Hawassa University Referral Hospital, Ethiopia. According to the 
National Cholesterol Education Program Adult Treatment Panel III (NCEP-
ATP-III) model guideline,34.9% of all diabetic patients had high LDL, high TC 
34.6%, high TG 29.8% and low HDL 12.2%.Also, the mean serum level of TC 
and LDL were higher in type 2 DM than in type 1DM. Females reported highly 
percentage of TC and LDL serum levels in comparison to males whereas males 
had lower HDL serum levels than females ( 48.04 ± 9.13 versus 51.93 ± 11.49 
mg/dl) (Ambachewet al., 2014). 
The study of Jayaramaet al. (2012) was carried out in Kolar India among 820 
T2DM patients between March 2010 and April 2012.In this study, the authors 
reported a high prevalence of dyslipidemia among diabetic men and women by 
95.4% and 86.75%, respectively .The pattern of this disorder among diabetic 
men was combined dyslipidemia with high triglycerides (TG) and low high 
density lipoprotein (HDL).Conversely, diabetic women had combined 
dyslipidemia with high low density lipoprotein (LDL) and low (HDL) 
(Jayaramaet al. 2012).   
One clinical study by Al-Adsaniet al. (2002) was done in Kuwait about the 
pattern and determents of dyslipidemia among 206 patients with T2DM.Their 
results showed high percentages of obesity by 57% and overweight 32% in 
addition to high TC by 67% , LDL 86% and TG by 25% and lowering HDL 
among males compared to females by 63% and 71%, respectively. 41% of 
dyslipidemia represented by an increase of LDL and a decrease of HDL levels 
and isolated increase of LDL was represented in 21% of study subjects(Al-
Adsaniet al., 2002). 
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2.1.4 Physical Inactivity: 
WHO defines physical activity (PA) as "any bodily movement produced by 
skeletal muscles that require energy expenditure – including activities 
undertaken while working, playing, carrying out household chores, travelling, 
and engaging in recreational pursuits" . Insufficient physical activity is one of 
the leading risk factors for CVD, diabetes, cancers (WHO, 2017). 
In the same context physical inactivity has negative effects on mental health, 
obesity and injuries . Globally, physical inactivity is considered the 4th 
leading risk for mortality worldwide contributing to3.2 million deaths 
worldwide (WHO, 2017).  
In Europe , annually,1 million deaths and 8.3 million disability-adjusted life 
years lost are attributable to physical inactivity .According to the WHO, one 
third of adults and 2 thirds of adolescents are insufficiently active . Physical 
inactivity, overweight and obesity and an unhealthy diet all are considered 
risk factors for diabetes .These account for 80% of the increase prevalence of 
DM .The presence of these risk factors along with diabetes will increase the 
risk of heart diseases which require more effort to achieve the global 
recommendation of activity (WHO, 2015).  
A study by Chudyk et al. (2009) was conducted to investigate the impact of 
the mode of exercise on cardiovascular (CV) risk factors in type 2 diabetes. A 
meta-analysis of 34 articles with systematic review of their literature between 
1970 and October 2009 in representative databases for the effect of aerobic or 
resistance exercise training on clinical markers of CV risk .The study showed a 
positive correlation between aerobic training alone or combined with resistance 
training (RT) significantly improved HbA1c −0.6 and −0.67%, respectively 
and in general improved systolic blood pressure (SBP), triglycerides, and waist 
circumference(Chudyk et al., 2009). 
A total of six cross sectional studies were conducted in Finland from 1972 to 
1977 and from 1982 to 1997 in order to assess the relation between physical 
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activity and CVD risk factors and mortality among diabetic patients type 2.The 
findings showed that people who are highly active have lower risk factors of 
CVD and mortality, while others who had low activity levels or who were 
inactive have higher risk and mortality (Gang et al. 2005). 
A cohort study was done in USA on 2803 male participants with T2DM aged 
from 30 years and older to study physical activity and its association with 
reduced RFs of CVD and mortality . During 14 years of fellow up the 
incidence of CVD was 266 and 355 of participants died , furthermore , results 
showed that walking was associated with reduced risk of total mortality , 
Brisk walking was inversely associated with CVD, fatal CVD and total 
mortality (Tanasescu et al., 2003).Another randomized control study in USA 
aimed to assess whether exercise improves quality of living (QoL) in adults 
with T2DM whereby the sample group of participants was subjected to 
aerobic and resistance training for a period of 9 months and compared with the 
non-exercise control group on hemoglobin A1C (HbA1c). The findings 
showed that general health was improved by aerobic and resistance training or 
a combination of both compared with the control group. Resistance training 
had modifying bodily pain whereas aerobic and combined condition groups 
improved the physical function of the body (Myers et al., 2013). 
In the  Arab countries, there have been many barriers for people being 
physically inactive . A literature review of 15 studies was conducted in the 
Gulf countries which aimed to assess the barriers and /or facilitators to PA. 
Findings show that lack of time and presence of diseases were the main 
barriers in addition to other reasons including  lack of interest and 
information about  the benefits of PA on health ,lack of  motivation, stress 
and spend long hours on the internet and computers (Benjamin et al. 2013). 
Physical inactivity has led to the  increase of  sedentary time behaviors among 
diabetic patients which, in turn, increases the risk of CVD. Having a 
sedentary lifestyle is considered one of ten leading causes of morbidity and 
mortality (WHO,2002). 
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As a point of fact, there is research- based evidence  linking it to many health 
risks including an increased risk of diabetes, cancers in particularly breast and 
colon cancer, metabolic syndrome, obesity and CVD .Sedentary lifestyle 
behaviors (SB) among diabetic patients along with physical inactivity 
increase the risk of CHD and stroke(Hicks , 2017) . 
Many studies linked between sedentary  lifestyle and other risk factors 
including obesity, uncontrolled HbA1c, ageing and dyslipidemia. A cross 
sectional study from Chile in 2010 aimed to estimate the impact of smoking , 
sedentary life style ,obesity and alcohol consumption on the prevalence of type 
2 DM showed that a sedentary  life style and obesity were significantly 
associated  with an increased  risk of type 2 DM .The latter can be avoided in 
52.4% of participants provided they were not obese .Additionally,64% of type 
2 DM were described as sedentariness and this percentage could be avoided 
by62.2%   if participants become active . (Bertoglia et al., 2010) . 
Maastricht study investigated the association of total amount and patterns of 
SB with type 2 DM and metabolic syndrome .Results showed that increasing 
hours of sedentary time was associated with increased risk to type 2 diabetes by 
22%  and with an increased 39% risk of metabolic syndrome  by 39% (Van der 
Berg et al., 2016) 
Another study was carried out in 15 members of the European union 
investigated the association between leisure-time, sedentary and non-sedentary 
activities with BMI and with the prevalence of obesity. Results showed the 
presence of a strong association between sedentary lifestyle and physical 
inactivity within obese and higher BMI individuals (Martínez-González et al. 
1999). 
 2.1.5  Smoking : 
Smoking is considered a major risk factor for many of chronic diseases such as 
CVD, chronic obstructive lung disease , asthma, cancers (CA) and other 
diseases (Chang et al., 2012).Approximately 7 million people die from tobacco 
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per year . More than 6 million of whom died as a result of direct smoking and 
the rest as a result of being passive smokers .More than 1 billion smokers 
(80%) live in low and middle –income- countries (WHO,2017).  
Several cohort studies have found a positive relationship between smoking and 
diabetes in Korea .One of these studies was done in 2009 and included 4,041 
men representing ex- and current smokers and never-smokers as the control 
group .The study examined the relationship between smoking and its effect on 
insulin resistance and beta-cell function on the incidence of type 2 
diabetes. The results showed a higher incidence of T2DM among ex – and 
current smokers in comparison to never smokers by 12.5%, 11.1% and 7.9% 
respectively (Chan et al., 2009). 
A prospective cohort study was conducted among men and women who were 
followed for 14 years on the association  between the number of cigarettes 
smoked and the incidence of T2DM . Results showed that smoking was a 
statically associated with increased the risk of diabetes and mortality , 
participants who smoked ≥20 cigarettes /day had increased risk for incidence 
diabetes .(Jee et al., 2010). 
Another Japanese study explored the impact of cigarette smoking on the 
incidence of Type 2 diabetes mellitus (DM) in middle-aged (35-60 years old) 
men .The study concluded that the relative risk of Type 2 DM among current 
smokers who smoked  ≥ 25 cigarette /day  compared with non-smokers was 
1.47 (95% confidence interval (CI) 1.14-1.92) and who smoked >30 cigarette 
/day   had relative risk of 1.73 (95% CI 1.20-2.48) compared with non-smokers 
(Uchimoto et al., 1999).  
A prospective cohort study by Barengo et al. (2017)in Finland aimed to 
examine the risk of CHD incidence and mortality among people with and 
without T2DM according to their smoking status. Type 2 smoker male and 
female patients had higher all-cause mortality than type 2 non-smoker patients . 
Also, male type 2 smoker patients had higher risk for CHD mortality than their 
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peers non-smoker (HR 6.15; 95% CI 4.22-8.96) and (HR 2.62; 95% CI 1.60-
4.29) respectively. The same was for women by 6.92 (95% CI 2.79-17.19)and 
(4.06 (95% CI 2.83-5.82) respectively. 
On the other hand, non-smoker, non-diabetic patients showed a low risk for 
CHD incidence (HR in men 3.00; HR in women 2.80) than smoker and diabetic 
patients (Barengo et al.,2017) 
National Studies : 
In general, there are lack of studies about the DM and other CDs, but some 
studies conducted in Gaza and West Bank searched of diabetes and its related 
to CVD . 
One of these studies conducted in West Bank aimed to assess the prevalence of 
microvascular and macrovascular complications of type 2  among Palestinians 
.The study results showed high prevalence rates of obesity by 74% ,  HbA1c 
concentration level was >9% among half of participants ,dyslipidemia was 
37.3%and hypertension was 23% .(Abu Halaweh et al, 2017) . 
Screening for diabetes and hypertension  were done by UNRWA and targeting 
7762 refugee in Palestine , Jordan , Lebanon and Syrian Arab Republic in 2007 
.findings showed 18.7% had HTN and 9.1% had DM with higher rates of 
obesity in Jordan and Palestine  by 32.7% in males and 53.7% in females and 
34.1% in males and 52.6 % in females respectively .Lebanon has the highest 
prevalence rate in smoking by 59.5% in males and 39.9% in females  . (Mousa 
etal.2010). 
Another study used mathematical Markov model conducted in Palestine aimed 
to estimate diabetic prevalence in the future and compare five future policy 
scenarios of diabetes prevention in presence of obesity and smoking as risk 
factors . prevalence . Results concluded that 22.1% of Palestinians males were 
obese and 37.2% among females and smoking prevalence was 53.7% among 
males  and 5.2% among females For DM prevention estimation in the future, 
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WHO , global and regional targets (EMRO) and two additional targets ,one 
feasible and one ideal were used the study showed that  diabetic prevention 
could be achieved if obesity trend start to decline ,5% reduction of obesity 
trends within 5 years will lead to 2.8% decreasing of diabetic prevalence and 
20% reduction if obesity trends decline to 35% within 10 years . (Abu-Rmeileh 
etal ,2013) . 
Cross sectional study have been conducted to determine the prevalence rate of 
HBP , in West Bank in 2011.  
The study targeted 2077 of adults older than 25 years in six governmental 
primary health care clinics in Hebron , Ramalla and Nablus .women 
represented 58% of the total participation .Results showed high prevalence rate 
among Palestinians by 28% (Lancet ,2013) 
In our study, we can't overlook the importance of HbA1c and its effect on the 
risk factors of CVD .WHO and ADA recommended HbA1c as a means to 
diagnostics DM with a cut point of 6.5% and less than 6.5%. For diabetic 
patients, HbA1c must be less than 7% (WHO, 2011). 
HbA1c and CVD : 
HbA1c reflects average plasma glucose over the previous 120 day of RBC life 
span. HbA1c is used in screening tests for individuals with a high risk of DM,  
and for diagnosis of diabetes, and it is used as marker test in monitoring and 
controlling DM. 
Many studies were conducted on HbA1c and its  association with CVD. One of 
these studies was conducted in China , and it aimed to examine the relationship 
between HbA1c and the complexity coronary artery lesions among the older 
patients with DM (World Health Organization, 2011).(PLOS , 2014) .Results 
showed that HbA1c is significantly associated with complex coronary artery 
lesions, and concluded that higher HbA1c levels among older diabetic patients 
are considered as independent risk factorof coronary artery lesions (Ma J et al, 
2014). 
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Another study was carried out in Saudi Arabia in 2006. It aimed at examining 
the impact of glycaemic control on the lipid profile of diabetic patients. The 
finding of this study showed a significant association between highHbA1c and 
TC, TG and low HDL-C, while LDL-C remained unaffected (Khan et al., 
2007) 
A  study was conducted in India, which aimed to examine the current HbA1c 
status, diabetes and the prevalence of Complications among Type 2 Diabetes 
Patients .The results showed that the mean of HbA1c was 9.2% and poor 
controlling for patients within long duration of diabetes (9.9±5.5 years) 
.Microvascular and microvascular were detect with a high prevalence rate due 
to poor glycemic control , the prevalence of cardiovascular complication 
(23.6%), renal (21.1%), eye (16.6%) and neuropathy (24.6%) complications 
(Mohan, Shahand, 2013).  
A cohort study was carried out in Sweden in 2012 and aimed to examine the 
relationship between glycemic control HbA1c and hospitalization for heart 
failure (HF). The findings showed that the risk of HF hospitalization increased 
with the high level of HbA1c as the hazard ratio (HR) was 1.2 % increment in 
concentration of HbA1c.Furthermore, there was a significant association 
between the incidence of (HF) and males, the long duration of diabetes and old 
age by a p value of (<.001 , <.001 and <.001) respectively (Marcuset al, 2012).  
A cross sectional study was done in Gaza aimed to to assess the level of good 
glycemic control, to determine association between adherence to anti diabetic 
medications and glycosylated hemoglobin (HbA1c) and to examine factors 
influencing good glycemic control. 
Results showed only one fifth of participants had good glycemic control ≤7% 
and the   
mean of  of HbA1c was 8.97% .Oder age , medication adherence and good 
health literacy were associated with good glycemic control while duration of 
diabetes >7 years was negatively associated .  (Radwan etal,2017) 
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Chapter Three 
 
Conceptual  Framework 
3- Introduction: 
This chapter presents the modifiable risk factors  and metabolic disorders 
(dyslipidemia , hypertension ,obesity ,smoking and physical inactivity) for 
CVD among insulin dependent type 2 patients. Patients with type 2 diabetic 
mellitus have a two-three-fold increased risk of heart attacks and stroke 
(Sarwar et al ,2010). Many diabetic patients exhibit a cluster of metabolic 
disorders  including obesity hypertension and dyslipidemia  which are  linked 
with a number of modifiable life style risk factors .  
Dyslipidemia : 
It is a manifested condition refers to an increase in one or more of plasma lipids 
concentrations , usually cholesterol and triglycerides. Cholesterol, 
Triglycerides and lipoproteins are normal physiological components in the 
body. Plasma lipids   represented a fundamental source to energy for 
metabolism and cell membrane homeostasis (Mahmood etal,2014) . 
Total Cholesterol is divided into three major components  , high density 
lipoproteins (HDL-C) , very low density lipoproteins (VLDL-C) , low density 
lipoproteins (LDL-C) that represent 60-70% of the total cholesterol  and 
considered  atherogenic  lipoprotein (NCEP,2002) . 
In diabetic patients with Hyperglycemia ,excessive glucose linked  to plasma 
proteins that producing insoluble complex components lead to changes of 
endothelial  cells. on the same hand , glycation of lipoproteins LDL-C  can 
prolong it's life span that increase their  risk to  accumulate in the vascular 
walls where it is more susceptible to oxidation  leading to  atherosclerosis 
(Haffner , 1998) . 
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Also patients with type 2 exhibit high triglyceride concentration with low 
HDL-C level in blood , elevation of  triglycerides are activating some of 
coagulant factors including ,factor  v11,factor X and plasminogen Activator 
Inhibitor-1  (PAI-1) which increase the platelets aggregation which may 
accelerate atherogenesis .( Basa & Garber,2001) . 
Many studies have concluded that elevated HDL-C  level can decrease risk of 
CHD , but some studies have gone further in focusing on the importance HDL-
C functions in cardiovascular protection , one of these studies was carried out 
in 2014 and concluded that HDL-C can play as inhibiter for inflammations and 
thrombin.  Apolipoprotein, apoA-1is one of the major components of HDL-C 
represented as  anti-atherogenic (Rye, Ong ,2014). 
Obesity : 
Overweight and obesity defined as abnormal fat that accumulated and may 
cause health problems and are measured by the body mass index (BMI). A 
person with a BMI equal to or more than 25 is considered overweight  and >= 
30 kg/m
2
 is considered obese (WHO, 2011).  Obesity is one of the major 
challenges faced the world , increasing rates of obesity may increase the risk of 
DM , CVD and other chronic conditions which reduce life expectancy for 
individuals .( Olshansky etal, 2005 ). 
Globally, 39% of adults aged ≥18 years were overweight with BMI ≥ 25 and 
more than half billion adults were obese  in 2014 with  6.3% of children under 
5 years old  in 2013.(WHO.2014). In Palestine obesity affects 26.8% of people 
(23.3% males ,30.8% females ) (WHO,2015) . 
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In Sweden study, it was concluded that obese type 2 patients have high 
prevalence rates of risk factors which increase the risk of CVD ( Ridderstråle 
Also several studies showed that the association between obesity   etal,2006).
and the risk of developing insulin resistance (IR) and type 2 DM (Kahn 
etal;2006 & Al-Goblan etal;2014) 
Obese patients with type 2  tend to develop insulin resistance (IR) , that 
adipose tissues release more of fatty acids, hormones, glycerol and 
cytokines ,all of these secretions increase of developing IR (Kahn 
etal;2006). Furthermore obesity is considered as an independent and  a 
major risk factor for CVD, and  the risk of CVD is increased for patients 
with type 2 DM. Moreover, people who are overweight with central 
deposition of adipose tissues showed high prevalence CVD mortality and 
morbidity (Van etal;2006) . 
It is important here to mention that obesity may be associated with 
dyslipidemia , HBP , DM and IR ,it is associated with incremental level of 
fibrinogen and C-reactive protein which increase the risk of CVD ( Ritchie & 
Connell; 2007). 
 Hypertension: 
It is one of the most important risk factor for premature CVD including 
, heart failure, atrial fibrillation and peripheral stroke, coronary heart disease
Globally , 13.5% of premature CVD et al.2014).  vascular disease ( Angeli
deaths were attributed to  hypertension and 54% of stroke and 47% of 
et al .  Lawesischemic heart disease events were accounted by hypertension ( 
2008 ). 
Hypertensive patients with DM having highly risk for death and disability  
(Campbell et al ,2011). In Canada, the mortality rate for people who are 
diagnosed with hypertension and diabetes is 2.5 time higher than who were not 
diagnosed  (Public Health Agency of Canada,2011) . 
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According to the Word Health Federation, hypertension is responsible for 50% 
of ischemic stroke and increase the risk of hemorrhagic stroke by damaging for 
blood vessels and increase plaque (Word Health Federation,2017) . 
Physical Inactivity: 
According to WHO physical inactivity is the fourth leading risk factor for 
mortality and increases the risk of DM , CHD, stroke and cancer by 20-30% 
and shortness lifespan 3-5 years (WHO,2018). Globally, 23%of adults and 81 
% of adolescents are not active enough and females tend to be more less 
inactive than males (WHO,2017). 
A meta analysis review of 21 prospective cohort studies aimed to examine 
the association between physical activity and the risk of CVD with 
population size 650000 who were free of CVD showed that 20000 incidence  
cases of CVD were reported. Furthermore, findings indicated  reduction of 
CVD risk factors by 20-30% with individuals who do vigorous level of 
activity and 10-20% who do moderate level of activity compared to others 
who do low level of leisure time (Li & Siegrist ,2012). 
Moreover, aging , overweight and obesity and sex are associated inversely 
with physical activity level and may increase risk of CVD ( DiPietro, 1995; 
Blair & Brodney,1999 & Singh etal,2016) . 
Smoking  
Smoking is considered one of the most risk factor of CVD and the second 
leading cause for CVD death after HBP ( Wong, 2014).  In 2000, more than 
1.5 million died from CVD, and more that 10% of those deaths caused by 
smoking  (Ezzati et al. 2005) .  
Smoking is associated with other risk factors such as dyslipidemia and HBP , 
Smokers having high blood concentration of Cholesterol, Triglycerides 
,LDL-C and low HDL-C concentration   (Keto etal, 2016). 
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 Smoking cessation can reduced mortality rates of Ischemic Heart Disease 
and cerebrovascular diseases (Organization for Economic Cooperation and 
Development, 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (2): Risk factors for CVD among insulin dependent type 2 patients 
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Chapter Four 
 
Methodology  
Introduction  
This chapter outlines the elements of research process which were utilized in 
the research study . It describes the study design , data collection procedures 
,sample size and data analysis as well as the ethical consideration .  
4.1  Study design 
A cross sectional descriptive  study was used to assess the prevalence rate of 
risk factors of CVD among diabetic patients type 2 and to examine  the 
relationship between these risk factors and the risk of having  CVD . Type 2 
diabetic patients attending governmental diabetic clinics in the Bethlehem 
Health Directorate have been targeted between July and October of 2016. 
A cross sectional design is suitable for studying the prevalence of health 
disorders related diseases and is considered as important in public health for 
estimating the burden of disease (Hennekens & Buring, 1987). This study 
design is also easy, quick and rather cheap (Setia, 2016). 
4.2  Target Population 
Approximately 757 diabetic patients were distributed over nine MoH diabetic 
clinics in the urban and rural areas of Bethlehem district  providing medical 
care for patients with type 2diabetes with 348 of them treated with insulin and 
409 treated with compound (insulin+ tablets) . 
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Table 1: Summary about diabetic patients who receive care at  the diabetic 
clinics in the Bethlehem Health Directorate 
 
 
 
 
 
 
 
 
 
 
 
4.3  Target Sample Size  
Five clinics were selected as mentioned in 3.4 p 40 representing 591 patients; 
one of these clinics was in Bethlehem city and the others were located in the 
nearby villages: Alúbeidiya,  Bet Fajjar, Za'atara and  Nahaleen as shown in 
table 2below. 
The sample size was calculated using Tomas Thompson equation: 
 
 
 
 
Patients number 
type 2 
(compound) 
Patients 
number type 
2 (insulin) 
No of 
patients 
Type 2 
Name of 
clinics 
43 25 68 Alúbeidiya 
41 19 60 Bet Jala 
25 20 45 Bet Sahoor 
41 42 83 Bet Fajjar 
6 40 46 Taqoo'a 
7 33 40 Za'atara 
221 158 379 
Central 
clinic 
10 5 15 Harmala 
15 6 21 Nahaleen 
409 348 757 Total 
 
     ppzdN
ppN
n



11
1
22
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N  = population size ,  
 
 Z =     Z-Score corresponding to the level of significance equal to 
0.95and 1.96 
 
 D =   The error rate is equal to 0.05 
  
 P =    The proportion of the property offers and neutral=0.50 . 
 
Approximately 233 patients were selected from the total number of 591 
patients who visited diabetes clinics in the period between July and December 
2016 by using the stratified sampling technique. 
After that, the weight percentage of each clinic in relation to the total five  
selected clinics was assessed by dividing the total number of patients in each 
clinic on the total of all patients in the five clinics for example central clinic 
percentage = 379/591=.64 % and so on for other clinics . Doing that reflects the 
real weight of the central clinic in the population of study. 
In order to know the sample size for each clinic, percentage weight of each 
clinic was multiplied by the total sample size (233); for example sample size of 
the Central clinic = .64 *233 = 149 participants . 
The last process was computing the percentage weight for patients with insulin 
and compound which was done by dividing the total number of patients treated 
with insulin on the total number of patients at the same clinic, for example the 
central clinic insulin percentage=158/379= .42 % and so on for other clinics 
and this isapplied in patients treated with compound. 
Finally, the number of participants of each clinic was computed by multiplying 
the percentage weight of patients with insulin or compound by the total sample 
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size of each clinic for example sample size of the Central clinic = 149*.42=62  
participants .and so on for each clinics  to get in the last 233 of participants. 
Table 2: Sample size per clinic and treatment methods 
Clinic Name 
Type 2 
(insulin) 
Type 2 
(compound) 
Total percentage 
Sample 
size 
Insulin 
Sample 
Percentage 
Compound 
Sample 
Percentage 
(%) 
Total 
Central  158 221 379 0.64 149 62 0.42 87 0.58  
Za3tara 33 7 40 0.07 16 13 0.83 3 0.18  
Alúbeidiya 25 43 68 0.11 27 10 0.37 17 0.63  
Bet Fajjar 42 41 83 0.14 33 17 0.51 16 0.49  
Nehalen 6 15 21 0.04 8 2 0.29 6 0.71  
Total 264 327 591 1.00 233 104  129  233 
 
4.4  Criteria of Selection: 
The five clinics were selected based on the ability to access the sample , and 
the location of the villages. The clinics were chosen representing the south , 
east and west of the city to be representative sample . Moreover , the fact that 
the clinics have the same devices in measuring weight, height and blood 
pressure was taken into consideration. 
4.5  Exclusion Criteria 
1-Patients who are treated with tablets only. 
2-Some clinics were excluded from the study including Bet Sahoor and 
Taqoo'a because some nurses were not cooperative in the sorting patient's 
records to facilitate access to the sample required . 
3-Devices were not standardized in all clinics which required to excluded some 
clinics including Bet Sahoor ,  Bet Jala and Taqoo'a . 
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4.6  Research Instrument 
3.6.1 Tool 1: Study questionnaire.  This questionnaire was filled by all study 
population.  It consists of four sections (See Annex for the English and Arabic 
versions), as follows:  
Section 1: includes demographic data including age, gender, education, address 
and income. 
Section 2: includes information about diabetes including, duration of disease, 
family history and the type of treatment provided. 
Section 3: addresses CVD and family history of CVD. 
Section 4:  This section was only filled by the non-CVD participants.  It 
includes smoking history ,blood pressure and lipids the last section of the 
survey addresses  physical activity intensity  : light, moderate (which require 
150 min every week) and the vigorous types of physical activity (which need 
75 min every week)(WHO, 2017). in addition to sedentary lifestyle . 
Tool 2: Objective assessment for patients without CVD 
1- Anthropometry measurements  
The weight parameter was measured by using weigh Beam Eye – Level 
detecto scale and height was measured by using Wall Mount Highest  
scale  
Body Mass Index (BMI) was calculated from the weight in kilograms divided 
by the square of the height in meters. 
In this research study, the BMI was used as an index for body weight . Some 
selected diabetic clinics like Beit Fajjar and the Central Clinic in Bethlehem 
used the waist circumference (WC) as an indicator for obesity and the rest of 
the diabetes clinics did not supported this standard which is the reason for 
adopting BMI only in this study. 
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2- Blood pressure  
It was measured through the auscultatory method or the manual method and 
it was measured for 3 times (10 min between each read and read) then the 
mean value was taken. 
3- Blood sample for: 
 Fasting blood sugar was measured  for Glycated hemoglobin 
(HbA1c), lipid profile (Cholesterol, HDL, LDL and 
triglycerides).Those blood tests  were analyzed by Enzyme 
Immunoassay which is known as ELISA or EIA for lipid profile 
tests. Reagents from Bio System company were used and performed 
through automated analyzer  named Chemwell (GlobalChemwell 
Manufacture /China ).  
 HbA1c test: It was measured by using high-performance liquid 
chromatography [HP1c]method using the automated analyzer from 
Trinity Biotech manufactures. 
 
Pilot Study: 
 
A pilot was conducted to detect any problems or ambiguous issues that might 
occur. It was launched in March 2016.The researcher filled a total of 20 
questionnaires of diabetic patients at the Central Diabetic Clinic in Bethlehem 
City with measurement of  highest , weight and blood presser for each 
participants and  had a blood sample for each one of them . Note that there 
were no problems or obstacles to remember  during the pilot  
 
4.7  Data Collection procedures 
The data collection started after  reviewing patients’ medical files in order to 
identify the patients with insulin and compound medication then we detect the 
percentage weight for patients with insulin an compound for each clinic in 
order to find the number of participants in our study. 
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We used simple random sample from computer program by using random 
numbers . 
After receiving the approval letter for conducting the study, the questionnaires 
were filled out for each participant by the researcher herself  . The researcher 
asked for their consent and agreement to participate before filling out the 
questionnaire. Through filling the questionnaire, the researcher measured blood 
presser (BP) three times , height and body weight without shoes. 
After filling out the questionnaire , the researcher sent the participants to the 
lab to draw a blood sample if he/she were fasting for at least 12-14 hours. If 
he/she were not fasting, they were asked to return to withdraw a blood sample 
when they were fasting within one week from the date of filling out the 
questionnaire. 
Fasting blood sugar was measured for glycated hemoglobin (HbA1c), lipid 
profile (Cholesterol, HDL-C, LDL-C and Triglycerides). 
4.8 Study operational definitions 
1-  Cardiovascular risk assessment for 10 years:  It is defined according 
to the United kingdom Prospective Diabetes Study risk engine 
(UKPDS). It is considered as. It is considered a specific risk engine for 
individuals with type 2 DM who are undiagnosed by heart diseases 
previously. UKPDS risk engine calculates automatically some of the 
risk factors of CVD including: duration of diabetes , gender, current age, 
ethnicity, smoking status, systolic blood pressure and concentration of 
HbA1c and HDL/TC ratio .UKPDS risk engine calculates the patient's 
risk factors as risk score then groups them as >10 % low risk , 10% - 
19% moderate risk and ≥20% high risk for CHD and stroke. It estimates 
the risk of onset of non-fatal and fatal coronary heart disease and non-
fatal and fatal stroke (The Oxford Center for Diabetes, Endocrinology 
and Metabolism, 2016). 
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2- Lipids: According to the United State National Cholesterol Education 
Program Adult Treatment Panel(NCEP-ATP) III guideline (2002) was 
followed . According to this guideline , the desirable cholesterol level 
is<200mg/dl , and the normal triglyceride level is <150mg/dl , the 
optimal  level of LDL was defined as LDL ≥ 100 mg/dl and low level of 
HDL was defined as HDL < 40 mg/dl. 
3- Physical activity and leisure time:  It is the exact tool used by the WHO 
for physical activity assessment. The International Physical Activity 
Questionnaire (IPAQ) which classifies PA according to the type, 
intensity, duration and frequency was used .IPAQ is one health indicator 
for diseases. Individuals with a highly active life meet the 
recommendations of WHO and are considered healthy . Others who are 
categorized as being moderately active have an increased risk of non-
communicable diseases including DM, obesity and hypertension. 
Individuals with low physical activity or who are inactive have a 
considerably very high risk for premature death from CVD. 
There are many types of PA including (Aerobic Activity , Muscle-
strengthening , bone-strengthening and Stretching activates) and intensity 
classified to  light , moderate and vigorous intensity (NIH, 2016) . 
As for the level of intensity, it is measured by Met (Metabolic 
Equivalents).WHO defined Met as ''the ratio of a person's working metabolic 
rate relative to the resting metabolic rate. One MET is defined as the energy 
cost of sitting quietly, and is equivalent to a caloric consumption of 1 
kcal/kg/hour''.  
WHO adopted guidelines to estimate the energy cost and person caloric 
consumption by assigning 4 METS to time spent in moderate activities and 8 
MITS to the time spent in vigorous activities (WHO, 2006).The same concept 
of the intensity of activity and MITS is followed in this study. 
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4.9   Data Analysis: 
Data was entered and analyzed by the using of SPSS version 17  by the 
researcher herself  in a collaboration with statistician .  
3.9.1  Descriptive analysis for all study participants  
Patient's  characteristics were presented by descriptive analysis as means and 
standard deviations (SD) for continuous data and as frequencies for categorical 
data using person Chi Square at p value less than 0.05.An independent t-test 
was used to show the gender differences in mean values of variables. 
3.9.2 Analysis for non-CVD participants data: A test of significance was 
pearson chi-square was performed for the comparison of distributions  of risk 
factors in male and female and according to 10 years risk level for developing 
CVD. Two tailed probability (P) value less than 0.05 was significant.  
Physical activity analysis was done according to the WHO Global Physical 
Activity Questionnaire (GPAQ) Analysis Guide .(WHO, 2006).  
3.9.3 Multivariate analysis was done for patients without CVD ,.binary logistic 
regression was used to identify predictors. 
4.10 Permissions and Ethical Considerations: 
Public Health School  at Al-Quds University reviewed the study proposal and 
approved it. A permission letter was sent to  MoH by the Public Health Faculty 
of Al-Quds University  (Annexes 3&4) . 
Patients’ consents was taken by informed consent verbally, after full 
explanation of the study and its objectives and their right to refuse. Patients 
were assured of the anonymity of participation and confidentiality of the data 
collected. 
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Chapter  Five 
 
Results 
Introduction  
This chapter presents the results of the study. This chapter comprises of two 
sections; first section contains the socio-demographic characteristics of the 
sample (233) and initial information about the duration of diabetes , family 
history , type of treatment and whether having or not having CVD .Second 
section presents results of participants who were  not diagnosed of CVD (133 
).Means and percentages of risk factors and other associations were calculated 
and presented. 
 
5.1 Section One  
 
5.1.1  Frequencies of the socio-demographic characteristics of the study 
population: 
 
The study population consisted of 233 participants out of which 100 (43%) 
were  previously diagnosed with CVD; 52% were males and 48% were females 
as shown in Figure 4.1 below. The remaining portion (133) of the sample were 
not having  CVD comprising 31.6% males and 68.4% females.  
There was a significant statistical difference with the gender parameter 
(p=0.002) whereby women were less having CVD compared to men as shown 
in table 3. Also there was a significant statistical difference in regard to 
working in paid job the job parameter (p=0.029). Working  status for diabetic 
patients who did  not have CVD were lower than diabetic patients with CVD as 
shown in table 4.3. 
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Figure  1: Percentages of diabetic patients with and without CVD. 
Table 3: Socio-demographic characteristics of the study population  
 
P-
value 
Diabetic 
Patients  with 
CVD (100) 
 
Diabetic Patients 
without CVD (133) 
 
Variable 
   Gender 
0.002 52 (52%) 42 (31.6%) Male 
48 (48%) 91 (68.4%) Female 
   Age group 
.126 4(4%) 3(2.3%) 35-44 
5(5%) 17(12.8%) 45-54 
38(38%) 56(42.1%) 55-64 
53(53%) 57(42.9%) ≥65 
   Residency 
0.458 30 (30%) 47 (35.3%) City 
70 (70%) 85 (63.9%) Village 
0(0%) 1 (.8%) Camp 
   Education 
0.359 42(42%) 63(47.7%) Level Low  
Diabetic 
Patients 
without 
CVD 
57% 
Diabetic 
Patients  
with CVD 
43% 
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Illiterate +Literate 
47(47%) 50(37.9%) Moderate Level 
(Elementary+ 
Preparatory+ 
Secondary) 
11(11%) 19(14.4%) High Level 
Tawjeh and above 
   Profession 
0.029 45(48.9%) 42(34.1%) Work 
Employee) 
Private interest 
Volunteer 
Laborer) 
47(51.1%) 81(65.9%) Not work 
Unemployed - but 
able to work+ 
Unemployed - 
Unable to work+ 
Retired+ Housewife 
   Monthly Income 
0.514 27(28%) 37(29%) <1000 NIS 
47(48%) 53(41%) 1001-2500 NIS 
20(20%) 27(21%) 2501-4000 NIS 
4(4%) 11(9%) >4000 NIS 
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5.1.2  Duration of diabetes ,family history and treatment among male and 
female participants: 
There were no statistical significant differences between diabetic patients with 
heart disease and those not having it in regard to  duration of DM, type of 
treatment and history of family as shown in table 4 . 
Table 4:Distribution of  duration of diabetes , family history and type of 
treatment among male and female participants . 
 
 
 
 
 
P –value Diabetic Patients with 
CVD N=100 
Diabetic Patients without 
CVD N= 133 
Variable 
female male female male  
 
0.753 
 
 
 
12(25%) 
 
10(19.2%) 
 
23(25.3%) 
 
13(31%) 
Duration of Diabetes 
1-9 y 
22(45%) 27(51.9%) 47(51.6% 25(59.5%) 10-19 y 
 14(29% 15(28.8%) 21(23.1%) 4(9.5%) ≥20 y 
 
0.176 
 
21(50%) 
 
18(43%) 
 
28(35%) 
 
13(33%) 
Family History 
First –Degree 
Relative 
 
Second  Degree 
Relative 
 
Mix 
  
5(12%) 
 
(7%) 
 
7(9%) 
 
5(13%) 
  
16(38%) 
 
21(50%) 
 
46(57%) 
 
22(55%) 
  
21(44%) 
 
20(38%) 
 
64(70%) 
 
24(57%) 
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5.1.3 Diabetic patients with CVD 
As we mentioned above 43% of diabetic patients were having CVD including 
Atherosclerosis , Heart Attack , Stroke and Myocardial Infarction . 
Atherosclerosis was the highest prevalent disease among other CVD with 73%, 
heart attack followed by 32%,then stroke by 29% while myocardial infarction 
had the lowest prevalence by 14%.as shown in table 4 . 
5.2Section Two : 
Diabetic patients without  CVD 
4.2.1 Risk factors for CVD  
Five risk factors for CVD among diabetic patients type 2 were studied. Those 
include: smoking, hypertension, dyslipidemia, obesity and physical inactivity. 
In general, all risk factors among diabetic patients were high except smoking , 
the majority of participants were non-smokers (93.2%) as shown in table 4.4  
Findings showed a statistical significant difference in T-Cholesterol and 
Obesity (p=0.0001) in which females had a higher prevalence of T-Cholesterol 
and obesity than males by  80.2% and  83.5% respectively. Moreover, results 
showed that 23.3% of participants were overweight. 
Hypertension was observed in 88 (66.2%)participants, however there is no 
significant differences according to gender.  
The physical inactivity risk factor was the highest in terms of prevalence 
among other risk factors by 86.5%. Data showed that the number of 
participants with moderate physical activity was12 (9%) while only 6 
(14.3%)of participants exercised vigorously as shown in table 4.4. 
It is important to note that P-value for physical inactivity and smoking were not 
computed because of the low rate prevalence . 
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Table 5: Distribution of CVD  risk factors among insulin dependent  type2 
according to gender:  
 
 
 
 
 
P-
value 
Total =133 
(100%) 
Female = 91 
(68.4%) 
Male = 42 
(31.6%) 
Risk Factors 
 No yes no yes No yes 
.271 45 
(33.8) 
88(66.2%) 28(30.8%) 63(69.2%) 17(40.5%) 25(59.5%
) 
Hypertension 
 
.0001 40 
(30%) 
93(70%) 18(19.8%) 73(80.2%) 22(52.4%) 20(47.6%
) 
T-Cholesterol 
 
0.124 102 
(76.7%) 
31(23.3%) 79(86.8%) 12(13.2%) 23(54.8%) 19(45.2%
) 
Overweight  
 
.0001 36(27 %) 97(73%) 16(17.6%) 76(83.5%) 21(50%) 21(50%) Obesity (3 
stages) 
       Physical 
Activity 
121 
(91%) 
12(9%) 86(94%) 5(5.5%) 35(83.3% 7(16.6%) moderate 
127 
(95.5%) 
6(14.3%) 91(100%) 0(0%) 36(85.7%) 6(14.3%) vigorous 
       Smoking  
124 
(93.2%) 
9(6.8%) 91(100%) 0(0%) 33(78.6%) 9(21.4%) Current 
120 
(90.2%) 
13(9.8%) 91(100%) 0(0%) 29(69%) 13(31%) Ex-Smoker 
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5.2.2. Distribution of  patients characteristics and CVD risk factors 
according to gender  
The overall mean(±sd) for age of diabetic patients (133) was 60 ± 9years as 
shown in table 4.5 .TC , TG and LDL-Cholesterol  results showed a significant 
difference in females  within (p=.004 , (p=.002) and (p= .015) respectively. 
Means of TC ,TG and LDL-Cholesterol  in  females were higher than men by 
193±45 ,195±24 and 113±40 respectively .Moreover , BMI  was higher in 
females than males with a significant difference in (p=.006) .The mean systolic 
blood pressure was 134±19 and the mean diastolic blood pressure was 78± 9 as 
shown in table 4.5 . 
Table 6:Distribuation  of means for participants’ characteristics and CVD risk 
factors by gender: 
p-value 
Total 
Mean ± 
std 
N=133 
Female 
Mean ± 
std 
N=91 
Male 
Mean ± 
std 
N= 42 
Characteristics  
.520 60±9 60 ±9 59 ±10 Age (years) 
.006 33.6±6 35.2 ±6 30.0±4 (BMI (KG/M² 
.631 134±19 134±19 135±21 Systolic BP (mmHg) 
.127 78.2±9 78±9 79±9 Diastolic BP (mmHg) 
.004 189±44 193±45 178±40 T Cholesterol (mg/dl) 
.015 107±40 113±40 94±37 LDL – C (mg/dl) 
.159 50±14 51±15 47±13 HDL – C (mg/dl) 
.002 184±17 195±24 178±25 Triglyceride (mg/dl) 
 20±13.2 0 20±13.2 Smoking(current and 
ex-smoker ) 
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5.2 .3 Cardiovascular risk assessment: 
The UKPDS risk engine was used to predict the risk of having non-fetal CHD, 
fetal CHD, non-fetal stroke and fetal stroke after 10 years .The UKPDS risk 
engine reflects the effect of the combined risk factors present in the patient, so, 
patients with higher number of risk factors are expected to predict higher risk 
for CHD and stroke, although this may not happen in reality.(Ahnet al., 2011). 
The Pearson Chi square test was done and the results showed that age is 
significantly associated with the risk of CHD (P=0.0001).The predicted 10-year 
CHD risk increased gradually as the age of participants increased. This was 
evident in all age groups except the age group between 35-44 years as shown in 
table 4.7. 
On the same hand HbA1c associated significantly with the risk of Non fetal 
CHD with (p value (0.042) and fetal CHD with (p value (0.0001). More than 
half of participants 78(58.6%) had their HbA1c more than 7% which predicted 
high risk to CHD. 
There were no association between gender, duration of diabetes blood pressure 
and T Cholesterol and the risk of CHD as shown in table 4.5. Current or ex-
smokers predicted low to moderate risk of CHD. 
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Table  7:Cardiovascular risk assessment for  diabetic patients  
p-
value 
High 
≥20 
Moderate 
10-19.99 
Low risk 
<10 
p-
value 
High 
≥20 
Moderate 
10-19.99 
Low risk 
<10 
variable 
        Age 
.463 0(0%) 2(5.4%) 1(1.5%) .0001 0(0%) 2(3.9%) 7(15.9%) 35-44 
 3(9.7%) 7(18.9%) 7(10.8%)  1(2.6%) 12(23.5%) 21(47.7%) 45-54 
 13(41.9%) 12(32.4%) 31(47.7%)  12(31.6%) 33(64.7%) 16(36.4%) 55-64 
 15(48.4%) 16(43.2%) 26(40.0%)  25(65.8%) 4(7.8%) 0(0%) ≥65 
        Duration of 
Diabetes 
.582 8(25.8%) 8(21.6%) 20(30.8%) .012 15(39.5%) 21(41.2%) 20(45.5%) 1-10 
17(54.8%) 24(64.9%) 31(47.7%) 13(34.2%) 21(41.2%) 24(54.5%) 11-20 
 6(19.4%) 5(13.5%) 14(21.5%)  10(26.3%) 9(17.6%) 0(0%) ≥20 
        Sex 
.118 12(38.7%) 15(40.5%) 15(23.1%) .034 17(44.7%) 16(31.4%) 9(18.2%) Male 
 19(61.3%) 22(59.5%) 50(76.9%)  21(55.3%) 35(68.6%) 35(81.8%) Female 
        SBP 
.301 12(38.7%) 9(24.3%) 13(20.0%) .113 14(36.8%) 13(22.5%) 7(15.9%) Normal 
 10(32.3%) 12(32.4%) 33(50.8%)  12(51.6%) 20(39.2%) 23(52.3%) Prehypertensti
on 
5(16.1%) 11(29.7%) 14(21.5%) 7(18.4%) 11(21.6%) 12(27.3%) High (stage 1) 
 2(6.5%) 4(10.8%) 4(6.2%)  2(5.3%) 6(11.8%) 2(4.5%) HBP(stage 2) 
 2(6.5%) 1(2.7%) 1(1.5%)  3(7.9%) 1(2%) 0(0%) Hypertensive 
crisis 
        HbA1c 
.000
1 
0(0%) 1(3%) 23(35%) .042 3(7.6%) 10(19.6%) 13(29.5%) <7% 
 2(6%) 7(19%) 22(34%)  20(52.6%) 31(60.8%) 23(52.3%) 7-8% 
 29(94%) 29(78%) 20(31%)  15(39.5%) 10(19.6%) 8(18.2%) >8% 
        T C 
.464 16(51.6%) 25(67.6%) 44(67.7%) .219 20(52.6%) 36(70.6%) 29(65.9%) Desirable  
 8(25.8%) 8(21.6%) 14(21.5%)  10(26.3%) 12(23.5%) 8(18.2%) Borderline 
high 
Fatal CHD Non-Fatal CHD 
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Non-fetal stroke risk assessment: 
Age was significantly associated with the risk of non fetal stroke (P=0.0001) as 
per the predicted 10-year. For age group 55-64 the risk was moderate  however, 
it was moderate-high for ≥ 65  years old as shown in table 4.8 . 
Duration of diabetes and HbA1c were significantly correlated with low risk of 
non-fetal stroke by (p-value 0.001 and 0.0001) respectively. 
  
7(22.6%) 4(10.8%) 7(10.8%) 8(21.1%) 3(5.9%) 7(15.9%) High 
        HDL-C 
.134 11(35.5%) 7(18.9%) 11(16.9%) 0.120 11(28.9%) 13(25.5%) 5(11.4%) low 
 17(54.8%) 20(54.1%) 35(53.8%)  22)57.9%) 26(51%) 24(54.5%) Borderline 
high 
 3(9.7%) 10(27%) 19(29.2%)  5(13.2%) 12(23.5%) 15(34.1%) High  
.134
1 
3(10.0%) 1(2.7%) 9(13.8%) .010
010 
1(2.6%)33 1110(19.6%
) 
2(4.5%) Smoking 
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Table   8:Comparison of significant RFs in diabetic patients according to stroke 
risk group . 
p-
value 
High 
≥20 
Moderate 
10-19.99 
Low risk 
<10 
variable 
    Age 
.0001 0(0%) 0(0%) 9(100%) 35-44 
0(0%) 1(2.9%) 33(97.1%) 45-54 
1(1.6%) 14(23%) 46(75.4%) 55-64 
19(65.5
%) 
9(31%) 1(3.4%) ≥65 
    Duration of 
Diabetes 
.001 7(12.5%
) 
8(14.3%) 41(73.2%) 1-10 y 
5(8.6%) 10(17.2%) 43(74.1%) 11-20 y 
8(42.2%
) 
6(31.6%) 5(26.3%) >20 
    Sex 
.053 9(45.9) 11(45.8%) 22(24.7%) Male 
11(55%) 13(54.2%) 67(75.3%) Female 
    SBP 
.501 6(30%) 5(20.8%) 23(25.8%) Normal 
7(35%) 8(33.3%) 40(44.9%) Prehypertenstion 
4(20%) 8(33.3%) 18(20.2%) High (stage 1) 
1(5%) 2(8.3%) 7(7.9%) HBP(stage 2) 
2(10%) 1(4.2%) 1(1.1%) Hypertensive 
crisis 
    HbA1c 
Non-Fetal stroke 
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5.2.4 :  Distribution of lipid profile levels in diabetic patients according to 
the ATP-111classification among male and female participants: 
Of the total 133 subjects, 30% had dyslipidemia (CI 95%, p =0.0001) in47.6%  
of males and 80.2% of females as shown in table 4.5 above. 
Findings showed more than third of patients had high Triglyceride 
concentration in blood with a statistical significance difference (p=.012) in 
which males had higher prevalence than women by 38.1% 
According to the NCEP ATP 111 classification border line high thresholds for 
TC, TG and LDL-C were ≥240,≥200 and ≥160 mg /dl respectively. Based on 
this categorization 13.5% had TC ≥ 240 mg/dl, 37.6% had TG ≥ 200 mg/dl and 
 .0001 0(0%) 0(0%) 24(27%) <7% 
0(0%) 1(4.2%) 30(33.7%) 7-8% 
20(100%
) 
23(95.8%) 35(39.3%) >8% 
    T C 
.870 7(63.6%
) 
9(56.3%) 44(66.7%) Desirable 
2(18.2%
) 
5(31.3%) 13(19.7%) Borderline high 
2(18.2%
) 
2(12.5%) 9(13.6%) High 
    HDL-C 
.075 5(26%) 6(25%) 18(20.2%) low 
14(70%) 15(62.5%) 43(48.3%) Borderline high 
1(5%) 3(12.5%) 28(31.5%) High 
.961 2(10.5%
) 
2(8.3%) 9(10.1 Smoking 
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11.3% had LDL-C ≥ 160 mg/dl. and 21.8% of participants had HDL-C <40 
mg/dl.  
Table 9: Distribution of the lipid profile parameters according to NCEP ATP 
III classification among males and females  : 
p-value Total Females Males  Variable  
 
 
N 133 
 (100%) 
N 91  
(68.4%)      
N 42  
(31.6%) 
  
    Total Cholesterol 
(mg/dl) 
.921 85(64%) 58(63.7%) 27(64.3
%) 
Desirable (< 200) 
 30(30%) 20(22%) 10(23.8
%) 
Borderline high 
(200-239) 
 18(13.5%) 13(14.3%) 5(11.9%
) 
High (≥ 240) 
    HDL-C (mg/dl) 
.868 29(21.8%) 20(22%) 9(21.4%
) 
Low(< 40 ) 
 72(54.1%) 48(52.7%) 24(57.1
%) 
Borderline high 
 (40-59 ) 
 32(24%) 23(25.3%) 9(21.4%
) 
High (≥ 60 
    LDL-C (mg/dl ) 
.874 61(45.9%) 41(47.1%) 20(48.8
%) 
Optimal (<100) 
 35(26.3%) 24(27.6%) 11(26.8
%) 
Near optimal (100 
-129) 
 17(12.8%) 11(12.6%) 6(14.6%Borderline high 
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) (130 -159) 
 7(5.3%) 6(6.9%) 1(2.4%) High (160 - 189) 
 8(6%) 5(5.7%) 3(7.3%) Very high (≥ 190 ) 
    Triglyceride 
(mg/dl) 
.012 57(42.9%) 45(49.5%) 12(28.8
%) 
Normal (<150 ) 
 26(19.5%) 12(13.2%) 14(33.3
%) 
Borderline high 
(150 -199) 
 50(37.6%) 34(37.4%) 16(38.1
%) 
High (≥200) 
 
5.2.5: Distribution and frequencies of physical activity intensity levels 
among males and females  
According to the American Heart Association on physical activity to achieve 
overall health, one needs at least 30 minutes of moderate –intensity exercise at 
least 5 days /week for150 minutes. Or one needs to have 25 minutes of 
vigorous exercise for at least 3days for75 minutes or a combination of 
moderate and vigorous intensity activity. 
In this study, results showed a low percentage of participants in both the 
moderate and vigorous physical activity groups (6.8%only) .Despite the low 
participation rate in physical activity in general, males had a higher 
participation rate than females as shown in table 4.8.Also results showed a 
decrease in the intensity level of physical activity, which did not reach the 
required level among participants such that 6.8% of participants did not exceed 
600 met as shown in table 4.8.  
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Table 10: Distribution and frequencies of physical activity intensity levels 
among males and females participants . 
Total =133 
(100%) 
Female =91 
(68.4%) 
Male =42 
(31.6%) 
PA intensity level 
115(86.5%) 86(94.5%) 29(69%) Inactive 
   Active 
9(6.8%) 4(4.4%) 5(12%) Low Active <600 MET 
8(6%) 1(1.1%) 7(16.6%) Moderate Active >600>3000 
Met 
1(0.8%) 0(0%) 1(2.3%) High Active ≥3000 Met 
 
5.2.6 Sedentary lifestyle  
Only 125 of 133 participants reported the number of hours they spent lying 
down and the rest did not. The mean was 12.1±3.3 with a range minimum of 3 
hours to a maximum of 19 hours per day was consumed. 
Age was significantly associated with SB (P=0.001), older age was reflected on 
the life style of participants with more wasted hours /day lying down 
.Furthermore sex and duration of diabetes were significantly associated with 
SB (p=.022) and p=.005 respectively  
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Table 11: Characteristics of study population and risk factors with compared of 
mean of hours of sedentary behaviors.  
 
 
p-
value 
Mean ±SD CHARASTARISTIC
S 
  Age 
.001 10.67±4.6
2 
35-44 
 9.66±2.75 45-54 
 11.71±3.3
8 
55-64 
 13.37±2.9
2 
≥65 
  Sex 
.022 10.76±3.7 Male 
 12.72±2.9
9 
Female 
  Duration of 
Diabetes  
.005 12.16±3.1
4 
1-9 y 
 11.46±3.7
4 
10-19y 
 13.79±1.3
8 
≥20 y 
  BP (mmHg) 
.838 11.74±3.8
8 
Normal 
 11.77±2.2Prehypertenstion 
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3 
 12.38±3.1
3 
HBP (stage 1) 
 14±3.08 HBP (stage 2) 
 12±75 Hypertensive Crises  
  T Cholesterol 
(mg/dl) 
.334 11.93±3.3
6 
Desirable  
 12.73±73 Borderline  
 11±3.17 High  
  Triglyceride (mg/dl) 
.513 11.99±3.4
9 
Normal 
 12.28±2.3
9 
Borderline 
 12.2±3.68 High 
  HbA1c (%) 
.548 12.18±3.0
6 
<7 
 11.46±3.6
1 
7-8 
 12.31±3.3
4 
>8 
  BMI 
.444 12.50±3.7 Normal 
 11.74±3.6
9 
Overweight 
 12.19±3,2
5 
Obesity 
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5.3 : Comparison of cardiovascular risk factors among diabetic patients 
without CVD residing in cities and villages 
 
Our study population consisted of 133 participants of whom47 (35.3%) 
residing in the city, and 85 (63.9%) residing in villages and only 1(.8%) 
participant lived in a refugee camp. The result showed that there were no 
associations between risk factors for CVD and the location of residency.    
Table 12:Means for risk factors according to residency   
P-Value Village City Risk Factor 
.559 133±20 135±18 SBP 
.271 79±9 77±8 DBP 
.589 191±44 186±44 TC 
.477 51±15 49±13 HDL-C 
.365 110±42 103±40 LDL-C 
.477 197±153 179±90 TG 
   BMI 
.801 20(23.5%) 10(21.7%) Overweight 
63(74.1%) 34(73.9%) Obesity 
   HbA1c 
.389 13(15.3%) 11(23.4%) <7% 
19(22.4%) 12(25.5%) 7-8% 
53(62.4%) 24(51.1%) >8 
11(13%) 9(19.1%) Physical Activity 
   Smoking 
 6(7%) 3(6.4%) Current Smoker 
 9(11.3%) 4(10.3%) Ex- Smoker 
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-HbA1c and cardiovascular risk factors predictors  : 
HbA1c was divided into two levels <8 and ≥8% and conducted logistic  
regression for risk factors including ,age, sex, duration of diabetes , family 
history , treatment smoking, blood pressure, total cholesterol , physical activity 
and sedentary behavior .the results in table 12 below showed that all risk 
factors for CVD were not statistically significant predictor of HbA1cin the 
logistic regression analysis. 
All the p-values are between 0.209-0.985 which is not significant at the level of 
0.05 and the odds ratio between 0.434-1.452 . 
Table 13: Logistic regression analysis of cardiovascular risk factors, adjusted 
OR and CI 95%. 
Risk  Factor P-value   OR CI 95% 
Age .985 1.001 .881-1.137 
Sex .592 1.297 .501-3.357 
Duration of Diabetes .944 .995 .877-1.130 
Family History .589 1.452 .375-5.632 
Treatment .472 1.358 .589-3.131 
Smoking .209 .434 .118-1.595 
Blood Presser .264 .593 .237-1.484 
Total Cholesterol .960 1.024 .401-2.615 
Physical Inactivity 
(vigorous) 
.892 .873 .124-6.128 
Physical Inactivity  
(Moderate) 
.449 .580 .142-2.373 
BMI .918 .956 .410-2.231 
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Chapter Six 
 
DISCUSSION AND RECOMMENDATIONDS 
Introduction 
This chapter is divided into two sections. Section one discussed the 
demographic characteristics, the duration of diabetes, family history and the 
type of treatment for all participants. Section two discussed the prevalence of 
CVD  risk factors among the participants who is not suffering from CVD.   
Section One 
A sample of 233 diabetic patients with type 2 diabetes was studied and a total 
of 100 participants (43%) were diagnosed with CV diseases , the remaining 
portion of the sample was not having  CVD comprising 31.6% of males and 
68.4% of females.  
The prevalence of CVD was 43% among diabetic patients, this is a high and 
alarming rate, indicating  the importance of developing  preventive, diagnostic 
and therapeutic interventions for managing diabetes and CV  risk factors . One 
of the major goals in treatment of diabetic patients is to reduce CVD burden in 
order to improve their quality of life, and to decrease disability and premature 
death (Cecilia et al. 2016).  
This result is congruent with a study done by (Wong et al. 2014) in inconsistent  
with a study by Juradoetal (2009)but still in agreement with this study that 
male participants showed a higher rate (52%) than females (48%). 
The high prevalence of CVD among participants was 43% and this may be due 
to the fact that diabetes is an independent risk factor for heart disease. 
According to  (Sowers et al. (2001)diabetes is a silent disease that may cause 
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heart problems before even being diagnosed. Moreover, this may refer to the 
ineffective treatment provided to the participants (Gædeet al. 2003). 
61.1 Description of  diabetic patients Characteristics 
The mean age of participants was 60±9 (males:59±10 and females: 60 
±9).Most participants in this study were 55 years and above whereby 91% out 
of 100 patients have CVD. The association between age and risk of DM and 
CVD is still  not understood and this may due to the genetic difference between 
elderly people , lack of understanding  of the  biology of aging and lack of  
studies about the effect treatment for elderly people( Halter et al., 2014). 
The majority of participants were above the age of 55of whom a small minority 
(1.5%) had a university level education. This might affect their  compliance 
with treatment and their exposure to CVD risks.  Bryant et al., (2004) 
concluded that patients with diabetes and low literacy have poor knowledge of 
their disease and may have difficulties learning the advanced self-care skills 
needed to improve their status . 
Approximately 30% of participants had a monthly income that exceeds 2500 
NIS and the rest of them ranged between less than 1,000 NIS to 2,500NIS. 
According to the PCBS, the poverty line for a family consisting of five persons 
is 2,293 NIS and the extreme poverty line is 1,832NIS (PCBS, 2011). 
According to Brown,(2009) The economic burden facing patients adversely 
affect their diseases  management and contribute to exposure to CVD risks . 
Moreover,  the bad economic conditions seem to be a strong barrier to the 
implementation of health policies which aim to improve the outcomes of non-
communicable diseases (Weaveret al. 2014).On the other hand the bad 
economic conditions seem to be a strong barrier to the implementation of 
health policies which aim to improve the outcomes of non-communicable 
diseases (Houle, et al. 2016). 
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6.1.2  Duration of diabetes  
In patients without CVD, there was no statistical significant association 
between the duration of diabetes and the presence of risk factors. However, 
results showed that participants with a duration longer than 9 years have high 
percentages of risk factors which may increase the risk of having CHD, stroke 
and other cardiovascular diseases. Wannamethee and colleagues (2011) found 
statistical significant association between duration of diabetes ( ≥8 years) and 
CHD risk factors. 
This calls for dealing with  diabetic cases with great effectiveness, screening 
and early detection  for any early complications related to the heart or other 
organs. In addition ,to increasing the awareness of patients about the 
seriousness of diabetes early after diagnosis . 
History of DiabetesFamily  3.1.6 
A total of 93%  of participants(87.2% of  male and 88.2% of females) 
regardless of with or without CVD reported a family history of diabetes .FH is 
considered as independent risk factor for type 2 diabetes (Meigs etal.2000 & 
Harrson . 2003).  
There is no evidence of the association between genetic factors in people with  
history of diabetes and incidence of diabetes, however, persons with bi parental 
FH were at high risk of type 2 diabetes (Scott etal .,2013). 
6.1.4  Prevalence of cardiovascular disease among diabetic Patients by 
gender 
Atherosclerosis was the highest prevalent disease (73%) among other CV 
diseases and this may be due to insulin  resistance among patients and its 
correlation with other metabolic syndrome including  dyslipidemia and 
hypertension in addition to obesity (Kashyap , 
Defronzo.,2007&DeFronzo,Ferrannini.,1991).Heart attack prevalence was  
32%,then stroke 29% while myocardial infarction had the lowest prevalence 
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14%.The prevalence of stroke and heart attack was higher in females than 
males. These findings are consistent with the Giorda study in which the 
incidence rate for stroke in  females was 6.3per 1000 person compared to 5.5 
per 1000 person  . Giorda et al.(2007). 
Section Two 
6.2.1  Prevalence of Risk Factors among Diabetic patients  without CVD . 
Overall, the results showed a high prevalence of risk factors for CVD  among 
type 2 diabetes patients .A high percentage of participants (86.5%) were under 
the lack of physical activity. Shazwani and his colleagues (2010) contributed 
the lack of physical activities among type 2 diabetes patients to lack of time 
and motivation, however, Benjamin (2015) concluded that environmental 
barriers such as lack of exercise facilities influenced patients participation in 
physical activities.  
Age and  sex of diabetes were statistical significant with SB. These results were 
congruent with  Bruguara and his colleagues study in 2016where prevalence of 
sedentariness was higher in females than males at early and older age .( 
Bruguara et, al .,2016). This might be explained by the fact that 42.9% of 
participants elderly and in general the majority of the participants were 
physically inactive. Furthermore, 80% of them is out of the work force due to 
disease, unemployment, in addition, to the fact that55.6% of females were 
housewives. 
Moreover, SB was statistical significant with duration of diabetes, this might be 
explained by the lack of motivation and persistence to introduce lifestyle 
changes among participants. These higher rates of physical inactivity and SB 
correspond with higher level of HbA1c . HbA1c is an important indicator to 
predict the risk of heart disease mortality and morbidity and control other risk 
factors. It is worthy to mention that the medical team has the responsibility to 
raise awareness for the patient on how to control his/her blood sugar and 
provide appropriate intervention in addition to treatment and to make greater 
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efforts to adjust the behavioral risk factors and work aggressively with diabetes 
incidence cases(Sotero, et al. 2013). 
Our study showed high HbA1c levels among patients with a mean value of 
8.7% (Male participants: 64.5% and female participants: 56%) and these 
findings are compatible with neighboring countries such as Jordan(Khattab, et 
al. 2010)and Lebanon (Noureddine et al. 2014) while in Canada, the situation 
seems to be better than in the Arab countries (Leiter, et al. 2013) in which 50% 
of participants was HbA1c level≤ 7% . 
In this study, approximately84.9% of the participants were aged 55 years or 
older and it is found in Yang et al. study (1997) that aging affect HbA1c. 
 Duration of diabetes have impact on HbA1c level.72.9% of 133 participants 
had diabetes for more than 10 years and the duration of diabetes influences 
HbA1clevels(Verma, et al. 2006, Khattab, et al. 2010, Noureddine, et al. 
2014).  
Furthermore , high prevalence rates of obesity, physical inactivity and 
dyslipidemia among patients could contribute to poor HbA1c control and 
increase risk of CVD especially heart failure(HF) (Badran& Laher, 2012& 
Power & Thomas, 2011). 
Obesity prevalence was high (73%) regardless of the sex  while 23.3% of 
participants were overweight which was higher than  Tanzania study (Damian 
et al. 2017) . There was statistical significant between obesity and gender; the 
average body weight for female participants was within moderate obesity 
class2, while, males were classified under obesity class 1 .This was inconsistent 
with the findings of two international studies from Romania and China 
(Adriana, 2013; Wang et al., 2013).  
The association between BMI and other metabolic diseases such as 
hypertension and dyslipidemia among diabetics was investigated by other 
researchers. Studies showed that a high BMI is positively associated with 
increased prevalence of hypertension and dyslipidemia (Bays et al. 2017 and 
Mogre, et al. 2014). Physical inactivity, Urbanization, unhealthy diet and 
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insulin resistance  all these factors associated with obesity which increase risk 
of CVD .( Ershow,2009 & Kasuga, 2006).  According to WHO, obesity, 
hypertension and diabetes together were responsible for 24% of the global risk 
of CV morbidity and mortality (WHO,2010). 
Approximately , 66.2% of patients  have hypertension and receive 
antihypertensive medication and this is higher than  Mussa and his colleges 
study  (2016) and Nouh, et al.(2017).There was no variation between means of 
systolic blood pressure (SBP) and diastolic blood pressure (DBP) between 
males and females. The mean value of SBP was 135 mmHg for males 
compared to 134mmHg for females and DBP mean values were 79mmHg and 
78 mmHg for males and females, respectively. These means indicate the 
achievement of the desired goal of controlling systolic and diastolic blood 
pressure as 140mmHg/90mmHg.On the other hand, there is a high prevalence 
of heart diseases in our study population which requires aggressive and 
effective intervention to control other risk factors (Lahham, 2009; Mengesha, 
2007). 
Although patients with hypertension were under control by medication ,poor 
management of lipids was observed. Approximately 93(70%)of participants 
were suffering from dyslipidemia  although they  receive Cholesterol-Lowering 
drugs and these findings are higher than the findings of a study done by Zhao et 
al. (2014) 
Findings showed high mean value of TC, TG and LDL-C by (189±44, 184±17 
and 107±40)respectively. TC and TG showed a significant statistical 
association in males and females by 189±44, 184±17respectively(p= 0.004,p= 
0.002) .This condition does not meet the criteria adopted by the American 
Diabetes Association (ADA) for treatment. 
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One of the approaches for treatment is statins therapy which is initiated in order 
to control lipids among patients in order to decrease their risk of CHD and 
other heart events. The ADA has adopted Standards of Medical Care in 
Diabetes to achieve this goal by detecting the possible target of T Cholesterol 
(TC)which should be <135 mg/dl, Triglycerides <150 mg/dl, LDL –Cholesterol 
<70 mg/dl where above of these limits should be treated and HDL-Cholesterol 
>50 mg/dl (Meyers et al. 2006).  
Our results showed that two-thirds of patients 93 (70%)suffer from 
hypercholesterolemia(p= 0.0001)even though they were treated with 
cholesterol –lowering drugs. The results were consistent with earlier studies on 
diabetes patients in Tehran (Ghoddusiet al. 2008) and in Tunis (Khiariet al. 
2006). 
Means of TC, TG and LDL-C were high in our study (189±44),(184±17) and 
(107±40) respectively while HDL-C was within the target value (50±14).This 
could due to the lack of physical activity , high rate of obesity and insulin 
resistance(Blaton, et al. 2008).In addition, various medications should be used 
to lower T Cholesterol levels in the blood. Statins are recommended for 
patients with diabetes for their effective role in reducing the risk of a heart 
attack and stroke (American Heart Association, 2017). 
The Palestinian Ministry of Health (MoH) provide only one item of Statins 
based on the Palestinian Essential Drugs List and this item is not available on a 
continuous basis. Therefore, the management of dyslipidemia currently is 
inefficient and needs more efforts from the MoH and medical community .  
Treatment of dyslipidemia should be parallel with the control of other risk 
factors in the body such as smoking, obesity, physical inactivity, high blood 
pressure, high levels of HbA1c and modifying the drugs policy in treatment 
management of dyslipidemia in diabetic patients. 
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Smoking had the lowest rate amongst other risk factors (6.8% among males 
and zero percent among females).Smoking cigarettes did not have a 
considerable load according to the results of this study as up to 85% had never 
smoked. These results were consistent  with the findings of studies conducted 
in Nablus and Tanzania studies by Lahham (2009) and Thunberg (2015). 
More than two thirds (68.4%) of the sample in this study were females  and 
63.9% of whom lived in rural areas which are usually conservative with 
regards to smoking (York et al. 2010). so ,80% of participants were out of 
workforce which may refer to refrain from smoking for economic reasons . 
6.2.2  Cardiovascular Risk Assessment: 
As was previously mentioned the UKPDS risk assessment was used to predict 
the level of risk for both CHD and stroke. This tool uses modified and non-
modified risk factors for each individual and computes the risk related to risk 
factors together . 
Type 2 diabetic patients have two to fourfold increased risk of incidence CHD 
and ischemic stroke  and have an increased risk of mortality by 1.5 to 3.6-fold 
(Sarwar, et al. 2010). 
CHD Risk Assessment: 
Age and HbA1c levels were positively correlated with an increased risk of both 
CHD and stroke, however,  duration of diabetes correlated with stroke. 
Participants  in this study showed a high prevalence of CVD risk factors with 
poor management including HbA1c, lipids and obesity.  
The study found that participants aged 44 years and younger were a low risk 
group for the  risk of CHD (fetal and non-fetal) and those who were aged > 44 
years of age were at moderate to high risk. These findings were consistent with 
a study by Camethon, et al. (2010) . 
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Female participants had a higher risk rate (61.3%) for fetal and non-fetal CHD 
in comparison to55.3% in males. This, however, does not mean that the 
situation for male participants is satisfactory; their data showed that 44.7% had 
a high risk of non-fetal CHD and more than a third were at high risk to fetal 
CHD and this is in agreement with Zaho et al. (2017) and Barzi& Woodward 
(2006) who reported that menopausal condition and other risk factors including 
obesity  increase the risk of CHD among females.  
In this study,  age is significantly associated with the risk of non-fetal CHD 
(P=0.0001).It can be concluded that aging with presence of other  risk factors 
play a major risk of CHD.(Dhingra,2012). This leads to the need for early 
detection of diabetes and the adoption of appropriate treatment options to avoid 
complications of other metabolic diseases associated with diabetes (Jousilahti, 
et al. 1999). 
There were no significant difference between the number of years of having 
diabetes and the risk of CHD. Participants with different durations of diabetes 
showed high rates in all categories low, moderate and high risk. This is 
indicative of the fact that diabetes itself, along with other factors such as age 
and sex, play a major role in increasing the risk of heart disease (National Heart 
Lung and Blood Institute (NIH), 2016).BP, TC and HDL-C contribute to 
increasing the risk of CHD despite of the fact that these risk factors might be 
under control or not. 
There were no significant difference between level of TC  and the risk of CHD. 
However, TC results showed that  participants with normal or borderline 
concentration levels (on medication) were at high risk to non-fetal CHD (79%) 
and  risk of fetal CHD(77.4%).This could be referred to the insulin resistance 
effect of each risk factor on other factors and the relation between them in 
addition to diabetes. 
HbA1c was strongly associated with the risk of fatal CHD(P=0.0001). This 
means that uncontrolled HbA1c>7% had a positive influence on increasing the 
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risk of CHD which is consistent with the study conducted by Zhao et al. 
(2014).  Therefore, it is important to maintain HbA1c levels <7% which keeps 
patients away from the risk of CHD. 
 
  Non-Fetal Stroke Risk Assessment 
Results showed significant statistical differences between age and non fetal 
stroke (p=0.0001),It can be due to the fact that age acts as an independent risk 
factor for CVD. 
Moreover, significant statistical differences was found between duration of 
diabetes and non fetal stroke (p=0.001).It appears that the duration of diabetes 
is significantly associated with the risk of ischemic stroke which is congruent 
to the findings of Banerjee et al. (2012). In addition significant statistical 
differences were found between HbA1c blood levels and non fetal stroke 
(P=0.0001).More than half of the participants had HbA1c level above 8% and 
this is consistent with the Chinese study's findings by Chen et al.(2016). 
Our results showed high rates of obesity, dyslipidemia, and hypertension which 
work inversely with the management of diabetes and increasing the risk of 
stroke and other CVD. Moreover, metabolic syndrome risk factors including 
hypertension, dyslipidemia and obesity in addition to hyperglycemia played a 
serious role whether separately or together in increasing the risk of stroke 
(Tuttolomondoet al. 2015). 
6.3 Locationof residency 
In this study, the association between diabetic patients (without CVD) lifestyle 
and the presence of risk factors was investigated.47(35.3%) of diabetic patients  
were living  in the city and 85(63.9%) in rural areas. Results showed that there 
was no significant statistical correlation between risk factors among diabetics 
according to their location of residency. However, diabetic patients living in 
villages showed high mean of TC,TG,LDL-C , and HDL-C which was 
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consistent with a study in Cameroon by Lissock, et al. (2011).Also results 
showed high mean of obesity, poor control of HbA1c blood levels and physical 
inactivity. These findings may refer to the need of more diabetic management 
awareness campaigns and outreach programs devoted to rural areas. Although 
diabetic patients might be encouraged by healthcare providers to perform 
physical exercises, long-term compliance is a major problem with physical 
activity programs. Many patients fail to maintain self-motivation. Moreover, 
Personal and environmental barriers are associated with failure to stay active 
(Thomas, et.al, 2004). 
 
Conclusion : 
Effective diabetic care requires first of all to identify patients at high risk of CV 
complications then targeting common modifiable risk factors that are 
associated with each other and increase the risk of CVD . Life style behaviors 
is one of the major obstacles in improving health status for patients with type 2. 
UKPDS is considered as a specific risk engine in identify patients with type 2 
at high risk of CVD ,but it is not enough that we need for essential evaluation 
for all applied  policies in DM through offered specific intervention to primary 
health care such as weight reduction , maintaining HbA1c level around 8% and 
controlling blood pressure . 
educational intervention is necessary to improve compliance of treatment , 
communications with medical team and improve diabetic outcomes .  
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Recommendations 
 
Based on the results of this study the following recommendations were 
concluded: 
The high prevalence of risk factors among diabetic patients shed light on  the 
importance of having proper prevention, treatment and intervention approaches 
to control those risk factors.  
It is of extreme important to modify the lifestyle of diabetic patients which 
could be achieved through continuous counseling provided by the medical team 
in the clinics and exchanging experiences between patients and sharing success 
stories in disease control and prevention in support groups. 
The Ministry of Health along with other sectors has a serious role in decreasing 
individuals’ relying on fast food  by legislating laws that fight unhealthy food 
served in restaurants as per international health standards which decreases 
obesity and overweight in addition to lipids among children, teenagers and 
adults. 
Frequent awareness campaigns about diabetes etiology, control, treatment, 
prevention of complications ought to be done through the use of media, 
schools, universities and others. 
Ministry of Health should expand its surveillance and early disease detection 
especially in the scattered villages for better control of T2DM. 
Decision-makers should take effective measures and policies for prevention  
monitoring and control of  DM prognosis and diagnosis.  
 
More care should be given to early detection of the CVD risk factors among 
diabetic patients . 
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Finally, there is a need for conducting similar studies to assess the prevalence 
rates for risk factors of CVD among diabetic patients in several areas in 
Palestine. 
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Annex 1 
Study questionnaire (English version ) 
 
 
 
غسوُا خؼٓبع 
Al-Quds University 
School of Public Health 
Master Degree in Health Policies and Management 
 
Survey 
 
Dear participants  
The researcher Ghada Ibrahim Shafout is conducting a study to complete her 
master's program in health policies and management on the "prevalence of 
certain risk factors for heart disease among type 2 diabetics approved in their 
treatment of insulin alone, insulin and medication tablets in some diabetes 
clinics in Bethlehem Health Directorate". You were chosen at random among 
reviewers of some health centers. The participation in this research is voluntary 
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and the information you give is confidential and will be used only for research 
purposes and will not affect the service provided to you. We hope you will 
cooperate with us in filling out this survey. 
Researcher: GhadaShafout Mobile: 0599313892 
 
V1 No. of Questioner____________  
Demographic Data  
V3  Clinic   :  1) Central Clinic  2)BeitFajjar 3) Za'tara 
4) Alúbeidiya                5)  Nahaleen 
 
 
V4   Sex: 1)Male  2) Female 
V5 Age in years: _______________ 
V6  Marital Status: 1) Married     2)Single 3 ) Divorced 4 ) Widow 
   5) Separated 
V7    Address: 1)City 2) Village / Town 3) Camp 
V8   Educational Level   
1) Illiterate 2) Literate 3)Elementary   
2) 4) Preparatory 5) Secondary                                              6) Tawjehi 
 7)Diploma 8)Bachelor                                           9)H. Diploma  
10) Master’s and above 
V19   Which of the following categories best describes your job over the past 
12 
Months ?  
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1 ) Government employee 2)Non-governmental employee 
3) Private work or institution4) Volunteer work without pay    
5)Housewife 6) Student  
7) Retiree 8)Unemployed - but able to work 
9) Unemployed - Unable to work10) Laborer88)Refused to answer 
 
V10  Average monthly income / NIS:_________________ 
 
S1    Part 1: History of Diabetes 
S1_1 How long have you had diabetes? 
The number in years:________ 
99) Don’t Know 
S1_2 Do any of your family members have diabetes?  
1) Yes                                                                              2) No (Skip to S2_4) 
S1_3 If yes, please specify from: (Select all that applies) 
1) Mother / Father 2) Brother / Sister 3) Son / daughter 
4)  uncle / aunt (father’s side) 5) uncle / aunt (mother’s side) 
6) grandfather / grandmother 
S1_4 What is the treatments prescribed by the doctor for the treatment of 
diabetes? 
1) Only insulin        2)Insulin& medication tablet together (compound) 
3) Medication tablets only 
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S2 Part II: Cardiology 
Note: Complete the questions of this part in full and then if the respondent 
answered yes to any question,  
S2_1 Do you have any form of cardiovascular disease?  
 
 1) Yes              2) No               3) Don’t Know                                                                                             
 
If the respondent answered no or do not know go to the second part S3 
 
If yes, complete the following questions S2_2  
 
2) No  1) Yes Did you suffer from:  
  Arteriosclerosis a 
  Myocardial infarction b 
  Heart Attack c 
  a stroke  d 
  Other(specify): _________ e 
 
 
S2_4 Do any of your family members suffer from heart disease for genetic 
reasons? 
1) Yes                                          2) No (if not , please  go to S3 ) 
S1_5 If yes, please specify from: (Select all that apply ) 
1) Mother / Father         2) Brother / Sister               3) Son / daughter 
4)  uncle / aunt (father’s side)         5) uncle / aunt (mother’s side) 
6) grandfather / grandmother 
 115 
 
If yes to any of the questions of Part II thank the respondent and end 
thequestionnaire . 
 
S3_1Part III: Smoking 
S3_1 Do you currently smoke any of the following types of tobacco, such as 
cigarettes, cigars or pipes, hubbly bubbly or argeela?  
1) 1) yes              2) No          8) Refused to answer 
If the answer is no or no answer, go to previous smoking questions. If yes, 
complete the following questions 
S3_2 Do you smoke any of these types daily (more than one choice) 
 
 Type of tobacco: 1) Yes  2) No  
a Cigarettes    
b Hand-made cigarettes    
c Bubbly/Argeela   
d pipe   
e cigar   
 
S3_3 How old were you when you started smoking: 
Age ( in years )  ------------ 2) Don't Remember  88) Refused to answer                         
S3_4 On average, how many of the following tobacco products do you smoke every 
day in the last month? 
Note: If the answer is that he does not smoke a particular type of the next we write 
the word (none) or zero writing and not numbers. 
 Type of tobacco The Answer  
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a Cigarettes   
b Hand-made cigarettes   
c Bubbly/Argeela  
d pipe  
 
Previous Smoking X: SMOKER 
S3_5 In the past, did you smoke on a daily basis? 
1) Yes              2) No          8) Refused to answer 
If no or refuse to answer (go to Part 4 S4), if yes complete the following 
questions: 
 
S3_6 How old were you when you stopped smoking? 
Age ( in years )  ------------ 2) Don't  Remember 
 
How long has it been since you stopped smoking? (Only one answer) 
______________  
 
 
S4 Part IV: Blood pressure 
S4_1Have you ever been diagnosed with high blood pressure? 
1)Yes                       2) No         3) Don't know 
If you do not or do not know (go to Part 5 of the S5), then complete the 
following  
Questions 
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S4_2 How long have you been diagnosed with hypertension? (Period in years)-
-------------- 
Note: if the period is less than one year please specify the number of months. 
 
S4_3 Do you take prescription medication prescribed by your doctor? 
 
1) Yes (go to Part V S5)           2) No               3) Do not know 
 
S5 Part V: Lipids 
S5_1 Have you ever been diagnosed with high cholesterol in your blood? 
 
1) Yes                                         2) No               3) Do not know  
 
If you do not or do not know (go to Part VI S6), if yes complete the following 
questions  
 
S5_2 How long have you been diagnosed with high cholesterol (period in 
years) 
Note: if the period is less than one year please specify the number of months 
 
 
S5_3 Are you taking cholesterol-lowering drugs prescribed by your doctor ? 
1) Yes (go to Part V S6)           2) No               3) Do not know  
 
S6 Part VI: Physical activity during leisure time 
First: vigorous  physical activities 
For the researcher: The following questions about the activities that you do 
during your leisure or recreation, such as sports, physical fitness, etc. (and now 
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I will ask you about the physical activities that you are doing during this time 
which lead to a significant increase in your In your heartbeat and breathing) 
S6_1 Do you do any vigorousphysical activity as sports such as: running 
quickly or weight training,   drilling, farm work or building workshop for at 
least 10 minutes continuously in your spare time? 
1) Yes          2) No               3) Do not know      4) Refused  the answer 
(If the answer is no,  or do not know or reject the answer, go to the question of 
moderate  physical activity, if the answer is yes, complete) 
  
S6_2 How many days per week do you exercise? 
Please choose from 1 - 7 days of the week 
Answer: ________        77) Do not know                88) Refused to answer 
S6_3 In an ordinary day, how much time (hours/ minutes) do you exercise? 
Time: hour: _____ min: ______ 77 (do not know        88) refused to answer 
 
Second:  Moderate  physical activity 
It leads to a small increase in your heartbeat or breathing such as: walking 
fast, swimming, riding a bike or playing volleyball 
S6_4 Do you do  any physical activity of moderate intensity to maintain fitness 
for at least 10 minutes continuously in a day during your spare time? 
1) Yes          2) No               3) Do not know      4) Refused  the 
answer 
If yes, complete, if no, do not know or reject answer, go to physical inactivity 
S6_5 How many days a week do you do these moderate physical activities? 
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Please choose from 1 - 7 days of the week 
Answer: ________        77) Do not know                88) Refused to answer 
S6_6 In a normal day: How much time (hours / minutes) do you exercise doing 
moderate physical activity? 
Time: hour: _____ min: ______      77) do not know        88) refused to answer 
 
Behavioral physical  inactivity: 
The following question involves sitting or lying down at work or at home or 
going to and from different places, or with friends. This includes the loss of 
sitting, reading, watching television, using computers, doing handicrafts 
(drawing or embroidery), etc. Includes sleep times 
Calculates the total time spent sitting at work, reading, watching TV, 
computer, etc.)S6_7 
S6_7 In an ordinary day how much time (hours / minutes) are you sitting or 
lying down (except for bedtime) ? 
 Time: hour: _____ min: ______      77) do not know        88) refused to answer 
 
Part 7: Laboratory Tests A1 
 
A1  Questioner  Number: ________                A2 Clinic Name: ------------- 
A3  Sample number in the study: __________  
A4 Mobile number of the participant (if desired) ------------------------------- 
Physical Measurements)S7) 
Measuring blood pressure, height and weight 
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blood pressure 
The first measurement of pressureS7_1 
S7_1Systolic pressure 
S7_2Diastolic pressure 
The second measurement of pressure 
S7_3Systolic pressure 
S7_3Diastolic pressure 
The third measurement of pressure 
S7_5Systolic pressure 
S7_6Diastolic presser       
 
S7_8Measurement of height and weight 
S7_8Measure length (for nearest cm) 
 
S7_9 Weight measurement (for nearest kg) 
 
Body Mass Index (BMI) 
S7_10 BMI  1) Normal weight    2) Overweight              3) Obesity  
Laboratory tests for HbA1C and lipid profile 
Note: The respondent should be fasting for 12-14 hours 
S7_11 Date of withdrawal of blood sample              /     /     
S7_12   HbA1C   %   
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Lipid Profile 
S7_14 Total cholesterol  mg/dl                                                   
S7_15 HDL – Cholesterol mg/dl 
S7_16 LDL – Cholesterol mg/dl 
Status classification: filled by the researcher  
S7_17Suffers from high cholesterol in the blood     1) Yes     2) No 
S7_18Suffers from low HDL  in the blood                 1) Yes       2) No 
S7_19Suffers from high LDL  in the blood                 1) Yes      2) No 
S7_20Triglyceride level in Blood mg/dl   
S7_21Suffers from high Triglyceride  in the blood       1) Yes       2) 
Annex 1 
Study questionnaire (Arabicversion ) 
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 عبٓؼخ اُوسغ
 ytisrevinU sduQ-lA
 ًِ٤خ اُظحخ اُؼبٓخ
 ٓبعؽز٤ط ؼ٤بؼبد ٝإزاضح طح٤خ 
 
يعذل اَخشبر  عىايم انخطىرة لأيراض انقهب بٍُ يرظً انسكرٌ انُىع انثبٍَ انًعبنجٍُ ببلأَسىنٍُ 
 ) فٍ يذَرَت  صحت بُج نحىdnuopmocوالأَسىنٍُ والأقراص   (
 
 
 
 
 الأػعاء أُشبضً٤ٖ
 رح٤خ ٝثؼس ،،
ثئعطاء زضاؼخ لاؼزٌٔبٍ ثطٗبٓظ أُبعؽز٤ط ررظض ؼ٤بؼبد ٝازاضح   غبدة إبراهُى شعفىطروّٞ اُجبحضخ 
ُ٘ٞع اُضبٗ٢  طح٤خ _ حٍٞ "ٓؼسٍ اٗزشبض ثؼغ ػٞآَ اُرطٞضح  لأٓطاع اُوِت ث٤ٖ ٓطػ٠ اُؽٌط١ ا
أُؼزٔس٣ٖ ك٢ ػلاعْٜ ػِ٠ الأٗؽُٞ٤ٖ ُٞحسٙ  ٝالأٗؽُٞ٤ٖ ٝالأهطاص  ك٢ ثؼغ ػ٤بزاد اُؽٌط١ ه٢  
ٓس٣ط٣خ طحخ ث٤ذ ُحْ"، ُوس ٝهغ الاذز٤بض ػِ٤ٌْ ػٖٔ ػ٤٘خ ػشٞائ٤خ ٖٓ ًبكخ أُطاعؼ٤ٖ ُجؼغ  
ب  رجو٠ ؼط٣خ ٝؼزؽزرسّ أُطاًع اُظح٤خ. إٕ أُشبضًخ ك٢ ٛصا اُجحش ؽٞػ٤خ ٝأُؼِٞٓبد اُز٢ رسُٕٞ ثٜ
كوؾ لأؿطاع اُجحش ُٖٝ رؤصط ػِ٠ اُرسٓخ أُوسٓخ ٌُْ ، آِٓ٤ٖ ٌْٓ٘ اُزؼبٕٝ ٓؼ٘ب ك٢ رؼجئخ ٛصٙ 
 الاؼزٔبضح.
 2983139950اُجبحضخ : ؿبزح شؼلٞؽ   عٞاٍ: 
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   : __________انرقى انًخسهسم نلاسخًبرة1V
 
 انبُبَبث انخعرَفُت
   ) ظػزطح3             ث٤ذ كغبض) 2  ) أُطًع٣خ1 :  انعُبدة3V
 ) ٗحبُ٤ٖ5                           ) اُؼج٤س٣خ4                         
 ) أٗض٠2  ) شًط1 انجُس: 4V
 ___________  انعًر ببنسُىاث : 5V
 ) أضَٓ/ح4 ) ٓطِن/ح3  ) أػعة/ػعثبء2 ) ٓزعٝط/ح1 انحبنت الاجخًبعُت: 6V
 ) ٓ٘لظَ 5 
  ) ٓر٤ْ3  ثِسح) هط٣خ/2  ) ٓس٣٘خ1  يكبٌ انسكٍ: 7V
  انًسخىي انخعهًٍُ : 8V
) إػساز١4  ) اثزسائ٢3  ) ِْٓ (٣وطأ ٝ٣ٌزت 2  ) أٓ٢ 1
) 8  ) زثِّٞ ٓزٞؼؾ7  ) اٜٗ٠ اُزٞع٤ٜ٢ ث٘غبػ6  ) صبٗٞ١5 
 ) ٓبعؽز٤ط كأػِ٠01 ) زثِّٞ ػبُ٢9 ثٌبُٞض٣ٞغ
 
 
  أٌ يٍ انفئبث انخبنُت َصف عًهك الأسبسٍ خلال الأَثً عشر شهرا انًبظُت  ؟ 9V
) طبحت ٓظِحخ 3) ٓٞظق ؿ٤ط حٌٞٓ٢                        2     ) ٓٞظق حٌٞٓ٢          1
           ) ضثخ ٓ٘عٍ5) ػَٔ رطٞػ٢  ثسٕٝ اعط       4اٝ ٓؤؼؽخ ذبطخ                 
                                       ) ؽبُت             6
 ٌُٝ٘خ هبزض ػِ٠ اُؼَٔ                 -) ػبؽَ ػٖ اُؼَٔ 8      ) ٓزوبػس       7
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) ضكغ 88         ) ػبَٓ          01ؿ٤ط هبزض ػِ٠ اُؼَٔ              -) ػبؽَ ػٖ اُؼَٔ 9
 الإعبثخ                                    
 
 ____________ ببنشُكم : \دخم الأسرة انشهرٌ  يخىسط 01V
 
 انجزء الاول: حبرَخ انسكرٌ 1S 
 ٓ٘ص ٓز٠ ٝأٗذ  ٓظبة ثٔطع  اُؽٌط١؟ 1_1S
 ) لا ٣ؼطف99     ---------ػسز اُؽ٘ٞاد 
 )     4_2S) لا ( اٗزوَ إُ٠  2  ) ٗؼْ1 ؟َٛ أ١ ٖٓ أكطاز ػبئِزي ٓظبة ثبُؽٌط١  2_1S
 إشا ٗؼْ، اُطعبء اُزحس٣س ٖٓ : ( اذزط ًَ ٓب ٣٘طجن ) 3_1S
 اث٘خ \) اثٖ  3  أذذ\) أخ  2 الأة \) الأّ 
  اُغسح\) اُغس6اُربُخ                  \)اُربٍ5اُؼٔخ         \) اُؼْ 4
 ٓب ٛ٢ اُؼلاعبد أُٞطٞكخ ٖٓ هجَ اُطج٤ت ٝ اُز٢ رأذصٛب ُؼلاط ٓطع اُؽٌط١ 4_1S
 ) أهطاص  ٝأٗؽُٞ٤ٖ ٓؼب2   ) الأٗؽُٞ٤ٖ  كوؾ1
 
 آطاع اُوِتاُغعء ااُضبٗ٢ :2S
 
(ٓلاحظخ : أًَ اؼئِخ ٛصا اُغعء ًبِٓخ  ٖٝٓ صْ اشا اعبة أُجحٞس ث٘ؼْ ػِ٠ ا١ ؼؤاٍ اٜٗ٢ الاؼزٔبضح 
 )
 
 ؟َٛ رؼبٗ٢ ٖٓ أ١ ٓطع ثبُوِت  1_2S 
 ) لا اػطف3) لا                        2 ) ٗؼْ1
 )  2S(إشا أعبة أُجحٞس   لا  أٝ   لا اػطف   اٗزوَ  إُ٠ اُغعء اُضبٗ٢  
 
 إشا أعبة ٗؼْ أًَٔ الأؼئِخ  اُزبُ٤خ : 2_2S
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 ) لا2 ) ٗؼْ1 َٛ ػبٗ٤ذ أٝ رؼبٗ٢ ٖٓ 
   رظِت أٝاٗؽساز ك٢ اُشطا٣٤ٖ a
   ٛجٞؽ ك٢  ػؼِخ اُوِت b
   أطجذ ثغِطخ هِج٤خ c
   اُسٓبؽ) أطجذ ثغِطخ زٓبؿ٤خ (عِطخ ػِ٠ d
   --------------اذطٟ  (حسز)  e
 
 
 
 
 َٛ ٣ؼبٗ٢ أ١ ٖٓ أكطاز  اُؼبئِخ أ١ ٖٓ أٓطاع اُوِت  لأؼجبة ٝضاص٤خ ؟  4_2S
 ( اشا لا اٗزوَ اُ٠ اُغعء اُضبٗ٢)   ) لا   2) ٗؼْ                     1
 إشا ٗؼْ، اُطعبء اُزحس٣س ٖٓ : ( اذزط ًَ ٓب ٣٘طجن ) 5_1S
  اث٘خ \) اثٖ  3  أذذ \) أخ  2 الأة \) الأّ 1
 عسح \)عس 6 ذبُخ                  \) حبٍ5 ػٔخ\) ػْ 4
 (إشا ٗؼْ  لأ١ ؼؤاٍ ٖٓ أؼئِخ اُغعء اُضبٗ٢   اشٌط أُجحٞس ٝاٜٗ٢ الاؼزٔبضح )
 
 
 اُغعء اُضبُش: اُزسذ٤ٖ3S
ٗٞع ٖٓ أٗٞاع اُزجؾ اُزبُ٤خ ٓضَ اُؽغبئط أٝ اُؽ٤غبض أٝ اُـِ٤ٕٞ. , اُ٘بضع٤ِخ  َٛ رسذٖ حبُ٤ب  أ١1_3S
 ) ضكغ الإعبثخ 88) لا                           2) ٗؼْ              1       .....اُد
إشا ًبٗذ الإعبثخ ٗؼْ ،  أًَٔ ٝ اشا ًبٗذ الاعبثخ لا  اٝ ضكغ الاعبثخ  اٗزوَ لاؼئِخ اُزسذ٤ٖ اُؽبثن،
 لأؼئِخاُزبُ٤خ:ا
 َٛ رسذٖ أ١ ٖٓ  ٛصٙ الأٗٞاع  ٣ٞٓ٤ب (أًضط ٖٓ ذ٤بض)2_3S
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 ) لا2 ) ٗؼْ1 أٗٞاع اُزجؾ 
   ؼغبئط a
   ؼغبئط ُق ٓظ٘ؼخ ٣سٝ٣ب b
   ٗبضع٤ِخ c
   ؿِ٤ٕٞ d
   ؼ٤غبض e
 
 ًْ ًبٕ ػٔطى ػ٘سٓب ثسأد اُزسذ٤ٖ: 3_3S
) ضكغ 88) لا أشًط                          2اُؼٔط ثبُؽ٘ٞاد: ________                     
 الإعبثخ 
 ك٢ أُزٞؼؾ ًْ ٖٓ ٓ٘زغبد اُزجؾ اُزبُ٤خ رسذٖ ٣ٞٓ٤ب ذلاٍ اُشٜط أُبػ٢ ؟(ػسز)4_3S
ط ًزبثخ ُٝ٤ػ (ٓلاحظخ: إشا ًبٗذ الإعبثخ اٗٚ لا ٣سذٖ ٗٞع ٓؼ٤ٖ ٖٓ اُزبُ٢ ٌٗزت ًِٔخ (لا ش٢ء) اٝ طل
 اضهبّ) 
 الإعبثخ أٗٞاع اُزجؾ 
  ؼغبئط a
 
  ؼغبئط ُق ٓظ٘ؼخ ٣سٝ٣ب b
  ٗبضع٤ِخ c
  ؿِ٤ٕٞ d
  ؼ٤غبض 
 
  REKOMS : Xاُزسذــــــــــــ٤ٖ اُؽبثن
 ك٢ أُبػ٢ َٛ ؼجن ُي اُزسذ٤ٖ ٣ٞٓ٤ب 5_3S
 ) ضكغ الإعبثخ 88) لا                           2) ٗؼْ                    1
 )، إشا ٗؼْ أًَٔ الأؼئِخ اُزبُ٤خ  4S(إشا لا أٝ ضكغ الإعبثخ( اٗزوَ إُ٠ اُغعء اُطاثغ 
 ًْ ًبٕ ػٔطى ػ٘سٓب رٞهلذ ػٖ اُزسذ٤ٖ ؟ 6_3S
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 ) لا أرصًط777  اُؼٔط ثبُؽ٘ٞاد ____________
 ٞهلذ ػٖ اُزسذ٤ٖ ؟ ( ؼغَ إعبثخ ٝاحسح كوؾ ): ______________________ٓ٘ص ٓز٠ ر7_3S
 
 ػـؾ اُسّاُغعء اُطاثغ: 4S
 َٛ ؼجن ٝإ رْ رشر٤ظي ٖٓ هجَ اُطج٤ت  ثبضرلبع ػـؾ اُسّ  ؟ 1_4S
 ) لا اػطف3) لا                 2) ٗؼْ                          1
 )، إشا ٗؼْ أًَٔ الأؼئِخ اُزبُ٤خ  5Sاُربٓػ(إشا لا أٝ لا ٣ؼطف ( اٗزوَ إُ٠ اُغعء 
 ٓ٘ص ٓز٠ رْ رشر٤ظي ثبضرلبع ػـؾ اُسّ ؟ (اُلزطح ثبُؽ٘ٞاد )؟ ______________2_4S
 (ٓلاحظخ : إشا ًبٗذ أُسح اهَ ٖٓ ؼ٘خ  اُطعبء رحس٣س ػسز الأشٜط)
 
 ؟ أزٝ٣خ ُؼلاط اُؼـؾ ٓٞطٞكخ ٖٓ اُطج٤تَٛ رز٘بٍٝ 3_4S
) لا 3   ) لا         2 )                         5S) ٗؼْ  ( اٗزوَ إُ٠ اُغعء اُربٓػ 1
 اػطف
 اُسٛ٘٤بداُغعء اُربٓػ :5S
 
 َٛ ؼجن ٝإ رْ رشر٤ظي ٖٓ هجَ اُطج٤ت  ثبضرلبع ٗؽجخ اٌُُٞؽزطٍٝ  ك٢ عؽٔي ؟1_5S
 ) لا اػطف 3) لا                          2    ) ٗؼْ1
 
 )، إشا ٗؼْ أًَٔ الأؼئِخ اُزبُ٤خ  6S(إشا لا أٝ لا ٣ؼطف ( اٗزوَ إُ٠ اُغعء اُؽبزغ 
 
 ٓ٘ص ٓز٠ رْ رشر٤ظي  ثبضرلبع ٗؽجخ اٌُُٞؽزطٍٝ  (اُلزطح ثبُؽ٘ٞاد )؟ _________ 2_5S
 (ٓلاحظخ : إشا ًبٗذ أُسح اهَ ٖٓ ؼ٘خ اُطعبء رحس٣س ػسز الأشٜط)
 َٛ رز٘بٍٝ أزٝ٣خ ُرلغ اٌُُٞؽزطٍٝ ٓٞطٞكخ ٖٓ هجَ  اُطج٤ت ؟ 3_5S
 ) لا اػطف3    ) لا   2)        6S) ٗؼْ  (اٗزوَ اُ٠  اُغعء اُؽبزغ 1
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 اُغعء اُؽبزغ : الأٗشطخ اُجسٗ٤خ أص٘بء ٝهذ اُلطاؽ6S
 أٝلا : الأٗشطخ اُجسٗ٤خ اُشبهخ 
ثٜب ذلاٍ ٝهذ كطاؿي أٝ الاؼزغٔبّ  ًبُط٣بػخ , اُِ٤بهخ ُِجبحش: الأؼئِخ اُزبُ٤خ ػٖ اُ٘شبؽبد اُز٢ روّٞ 
اُجسٗ٤خ  ....اُد ( ٝا٥ٕ ؼٞف أؼأُي ػٖ الأٗشطخ اُجسٗ٤خ اُشبهخ اُز٢ روّٞ ثٜب ذلاٍ ٛصا اُٞهذ ٝاُز٢ رؤز١ 
 اُ٢ ظ٣بزح ًج٤طح ك٢ ػطثبد هِجي ٝ اُز٘لػ).
ثسٗ٢ شس٣س شبم ًبُط٣بػخ ٓضَ: اُغط١ ثؽطػخ أٝ حَٔ اش٤بء  َٛ روّٞ ك٢ ٝهذ كطاؿي  ث٘شبؽ1_6S
 زهبئن ٓؽزٔطح ػِ٠ الأهَ 01صو٤ِخ ،اُحلط ، اُؼَٔ ك٢  أُعضػخ أٝ ٝضشخ ث٘بء ) ُٔسح 
  ) ضكغ الأعبثخ4) لا أػطف             3) لا                       2) ٗؼْ                      1
طف  أٝ ضكغ الإعبثخٗزولإُ٠ ؼؤاٍ الأٗشطخ اُجسٗ٤خ أُزٞؼطخ. إشا ًبٗذ (إشا ًبٗذ الإعبثخ لا , لا أػ
 الإعبثخ ٗؼْ  أًَٔ)
 ك٢ الأؼجٞع اُؼبز١ ًْ ٣ٞٓب روّٞ ثٔٔبضؼخ ٛصٙ الأٗشطخ اُجسٗ٤خ اُشس٣سح 2_6S
 ػسز أ٣بّ الأؼجٞع) 7 – 1(اُطعبء الاذز٤بض ٖٓ 
   خ) ضكغ الإعبث88) لا أػطف            77 الإعبثخ: ________
 ك٢ اُ٤ّٞ اُؼبز١، ًْ ٖٓ اُٞهذ( ؼبػخ / زه٤وخ )   روّٞ ثٔٔبضؼخ  الأٗشطخ اُجسٗ٤خ اُشس٣سح 3_6S
 ) ضكؼبلإعبثخ88  لا اػطف ) 77 اُٞهذ: ؼبػخ: _____ زه٤وخ: ______
 
 صبٗ٤ب الأٗشطخ اُجسٗ٤خ  أُزٞؼطخ 
أُش٢ اُؽط٣غ أٝ اُؽجبحخ أٝ ضًٞة ٝٛ٢ اُز٢ رؤز١  إُ٠ ظ٣بزح  هِ٤ِخ  ك٢ ػطثبد هِجي أٝ ر٘لؽي ٓضَ : 
 زضاعخ أٝ ُؼت اٌُطح اُطبئطح
َٛ روّٞ ك٢ ٝهذ كطاؿي  ث٘شبؽ ثسٗ٢ ٓزٞؼؾ اُشسح ثؽ٤ؾ  ُِٔحبكظخ ػِ٢ اُِ٤بهخ  ُٔسح لا روَ ػٖ 4_6S
 زهبئن ٓؽزٔطح ك٢ اُ٤ّٞ ؟ 01
  الإعبثخ        . ضكغ) 4لا أػطف            ) 3لا                    ) 2) ٗؼْ                  1 
(إشا ًبٗذ الإعبثخ ٗؼْ  أًَٔ، إشا ًبٗذ الإعبثخ لا أٝ لا أػطف أٝ ضكغ الإعبثخ، أٗزولإُ٠ ؼؤاٍ اُرٍٔٞ 
 اُجسٗ٢) 
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 ًْ ٣ٞٓب ك٢ الأؼجٞع اُؼبز١ روّٞ ثٔٔبضؼخ ٛصٙ الأٗشطخ اُجسٗ٤خ أُزٞؼطخ  ؟5_6S
 ػسز أ٣بّ الأؼجٞع) 7 – 1اُطعبء الاذز٤بض ٖٓ 
 ) ضكغ الإعبثخ      88) لا أػطف            77 _____الإعبثخ: ___
 ك٢ اُ٤ّٞ اُؼبز١: ًْ ٖٓ اُٞهذ( ؼبػخ / زه٤وخ )   روّٞ ثٔٔبضؼخ  الأٗشطخ اُجسٗ٤خ أُزٞؼطخ.؟6_6S
 ) ضكغ الإعبثخ 88  لا اػطف ) 77 اُٞهذ: ؼبػخ: _____ زه٤وخ: ______
 
 : ؼًِٞ٤بد اُرٍٔٞ اُجسٗ٢
ثبُغِٞغ أٝ الاؼزِوبء ذلاٍ اُؼَٔ أٝ ك٢ اُج٤ذ أٝ اُصٛبة ٖٓ ٝإُ٠ الأٓبًٖ أُرزِلخ اُؽؤاٍ اُزبُ٢ ٣زؼِن 
، أٝ ٝأٗذ ٓغ الأطسهبء ٝٛصا ٣شَٔ اُٞهذ اُص١ روؼ٤خ عبُؽب   أٝ اُوطاءح أٝ ٓشبٛسح اُزِلبظ أٝ اؼزرساّ 
 أٌُج٤ٞرط ، ػَٔ أش٤بء ٣سٝ٣خ ( ضؼْ أٝ رطط٣ع ) ...اُد ٌُٖ لا رشَٔ أٝهبد اُّ٘ٞ
ت أُغٔٞع اٌُِ٢ ُِٞهذ اُص١ ٣وؼ٤ٚ عبُؽب ك٢ اُؼَٔ , اٝ اُوطاءح , اٝ ٓشبٛس ح اُزِلع٣ٕٞ , أٝ (٣حؽ
  اٌُٞٓج٤ٞرط ..اُد)
 ك٢ اُ٤ّٞ اُؼبز١  ًْ ٖٓ اُٞهذ ( ؼبػخ / زه٤وخ ) رٔؼ٢ عبُؽب أٝ ٓؽزِو٤ب ( ٓب ػسا ٝهذ اُّ٘ٞ ). 7_6S
 ؼبلإعبثخ) ضك88  لا اػطف ) 77 اُٞهذ: ؼبػخ: _____ زه٤وخ: ______
 اُغعء اُؽبثغ : اُلحٞطبد أُرجط٣خ 7S
 اؼْ اُؼ٤بزح :____________________ 2A ضهْ الاؼزٔبضح: ________                     1A 
ضهْ أُٞثب٣َ ُِٔشبضى (اشا ضؿت)  4Aضهْ اُؼ٤٘خ  ك٢ اُسضاؼخ : _________          3A
 :___________
 )stnemerusaeM lacisyhPه٤بغ ػـؾ اُسّ ٝاُطٍٞ ٝاُٞظٕ(
 ػــــؾ اُــــسّ
 اُو٤بغ الاٍٝ ُِؼـؾ
 اُؼـؾ الاٗوجبػ٢  =1_7S
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 اُؼـؾ الاٗجؽبؽ٢  =2_7S
 اُو٤بغ اُضبٗ٢ ُِؼـؾ
 اُؼـؾ الاٗوجبػ٢  =3_7S
 اُؼـؾ الاٗجؽبؽ٢  =4_7S
 اُو٤بغ اُضبُش ُِؼـؾ
 اُؼـؾ الاٗوجبػ٢ = 5_7S
         اُؼـؾ الاٗجؽبؽ٢ = 6_7S
 ه٤بغ اُطٍٞ ٝاُٞظٕ
 ه٤بغ اُطٍٞ ( لأهطة ؼْ )                                    8_7S
 ه٤بغ اُٞظٕ ( لأهطة ًـْ )9_7S
 
 )xedni ssaM ydoBأُؤشط اُسُ٤ِ٢ ٌُزِخ اُغؽْ ( 
 )stseT baLاُلحض أُرجط١ ُِؽٌط١ ٝاٌُُٞ٤ؽزطٍٝ ٝاُسٛ٘٤بد  (
 ؼبػخ         41-21ٓلاحظخ : ٣غت إ ٣ٌٕٞ أُجحٞس طبئْ ٖٓ 
 :اُؽٌـــط١
 /    /  ربض٣د ؼحت ػ٤٘خ اُسّ    11_7S 
 ٗؽجخ اُؽٌط اُزطأً٢  ك٢ اُسّ %            21_7S
 :طٍٝاٌُُٞ٤ؽزـــــ
 ٗؽجخ اٌُُٞؽزطٍٝ اٌُِ٢ ك٢ اُسّ:  ِٓـْ / زٍ                                 41_7S
 ك٢ اُسّ :       ِٓـْ / زٍ   C-LDHٗؽجخ  51_7S
 ك٢ اُسّ :        ِٓـْ / زٍ    C-LDLٗؽجخ 61_7S 
 ) لا2) ٗؼْ                 1٣ؼبٗ٢ ٖٓ اضرلبع اٌُُٞؽزطٍٝ اٌُِ٢ ك٢ اُسّ           71_7S
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 ) لا2) ٗؼْ                 1ك٢ اُسّ                     C-LDH٣ؼبٗ٢ ٖٓ اٗرلبع  81_7S
 ) لا2) ٗؼْ                 1ك٢ اُسّ                        C-LDL٣ؼبٗ٢ ٖٓ اضرلبع  91_7S
  edirecylgirTاُسٛ٘٤ـــبد :  
 ٗؽجخ اُسٛ٘٤بد ك٢ اُسّ :  ِٓـْ / زٍ   02_7S
 2) ٗؼْ                 1                      ٣ؼبٗ٢ ٖٓ اضرلبع اُسٛ٘٤بد ك٢ اُسّ  12_7S
 
 
 
 
 
 
 
 
 
 
 
 
